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This study investigated the utility of the Personality Assessment Inventory (PAI) 
for diagnosing and discriminating between Major Depressive Disorder (MDD) and 
Generalized Anxiety Disorder (GAD) with university counseling center clients. 
Participants were 1541 male and female students who received services at a student 
counseling center at a large university. Participants were classified as MDD, GAD, or 
Other Diagnosis (OD) based on the diagnosis determined by the treating clinician, and 
PAI profiles were compared between the three groups. 
The PAI Structural Summary-Revised contains Diagnostic Consider Clusters 
(DCC) that were designed to identify PAI scales/subscales that are typically elevated or 
suppressed when a particular disorder is present. The DCC’s for MDD and GAD were 
examined and the results demonstrated that the criteria for the DCC for MDD were met 
by 2.2% of the MDD group, and the criteria for the DCC for GAD were met by 3.8% of 
the GAD group. A discussion of these findings is offered, and the appropriateness of 
using the DCC’s for the purpose of diagnosis with any population is questioned. 
Additionally, DCC’s for MDD and GAD for use with university counseling center clients 
are proposed. 
Finally, discriminant analysis (DA) was employed to develop various 
discriminant functions that can be used to classify individual PAI profile data into 
specific diagnostic groups. In particular, one discriminant function was created that is 





discriminant function was produced that can analyze any PAI profile and categorize it as 
either GAD or OD. The final discriminant function was developed to evaluate a PAI 
profile that represents either MDD or GAD and determine which diagnosis is appropriate. 
Each discriminant function was shown to accurately predict the associated diagnoses. A 
discussion of the various predictor variables is offered. Taken together, these results 
support the use of the PAI for diagnosing and discriminating between MDD and GAD 
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CHAPTER I: INTRODUCTION 
 
Statement of the Problem 
As defined by the text revision of the fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV: Text Revision; American Psychiatric 
Association, 2000), Major Depressive Disorder (MDD) and Generalized Anxiety 
Disorder (GAD) represent two of the most commonly occurring psychological disorders 
(see Appendix A and Appendix B for the respective diagnostic criteria for MDD and 
GAD). Additionally, data collected during a recent 40-month period at a large university 
counseling center showed that MDD and GAD were the two most frequently diagnosed 
disorders. In the 2009 Pilot Study (Locke, 2009) from the Center for the Study of 
Collegiate Mental Health (CSCMH), data was collected using a standardized data set in 
the fall semester of 2008 from over 28 thousand students who received mental health 
services at 66 college and university counseling centers. These data demonstrated that the 
same types of clients and problems tend to be seen by all counseling centers regardless of 
their parent institution (Locke, 2009). Together, these findings suggest that MDD and 
GAD are the two psychological disorders most generally treated at university counseling 
centers. 
In addition to the high prevalence rates, the symptoms of MDD and GAD cause 
clinically significant distress or impairment in one or more important areas of functioning 
(DSM-IV: TR; APA, 2000). In fact, the CSCMH study found that level of academic 





(Locke, 2009). Due to the frequency of these disorders among university counseling 
center clients and the significant impact they have on an individual’s well-being, it is 
important that each disorder be accurately identified and treated appropriately. 
One aspect of this process requires discriminating between MDD and GAD when 
developing a diagnosis and this process can be complicated by certain issues. In 
particular, concerns exist regarding the somatic symptoms of GAD in that they almost 
entirely overlap with those of major depression (Roemer, Orsillo & Barlow, 2002). In 
fact, Brown, Marten, and Barlow (1995) found that the associated symptom criterion for 
GAD in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV; American Psychiatric Association, 1994) did not significantly discriminate 
patients with GAD from those with MDD or Dysthymic Disorder. Therefore, in addition 
to the aforementioned concerns these disorders represent in university counseling centers, 
difficulties exist in creating accurate differential diagnosis of the disorders. 
Throughout the process of psychodiagnostic assessment, psychologists frequently 
form and test clinical hypotheses based upon data collected from psychological 
assessment instruments (Spengler, Strohmer, Dixon, & Shivy, 1995). The Personality 
Assessment Inventory (PAI; Morey, 1991) has become one of the more commonly used 
tests for measuring psychopathology and psychological functioning (Belter & Piotrowski, 
2001; Boccaccini & Brodsky, 1999; Piotrowski & Belter, 1999). The PAI contains 344 
items that comprise 22 non-overlapping scales including 4 validity scales, 11 clinical 





a description of the PAI clinical, treatment, and interpersonal scales. Kurtz and Blais 
(2007) note that additional research should be conducted to determine the validity and 
utility of using personality measures like the PAI to aid in psychodiagnosis. 
In his development of the PAI Structural Summary-Revised, Morey (2007a) 
created diagnostic consideration clusters (DCC) that are based on both the content of the 
PAI scales (Morey, 1991) and on the results of studies that have examined specific 
diagnostic groups for typical scale elevations and suppressions (Morey & Hopwood, 
2007). The DCC’s were designed to identify PAI scales/subscales that are typically 
elevated or suppressed when a particular disorder is present. See Appendix D for a 
description of the DCC’s for MDD and GAD. In addition to using the respective DCC to 
aid in the diagnosis of MDD and GAD, Morey and Hopwood (2007) suggest that the 
DCC’s can be useful for differential diagnosis. 
The DCC’s for GAD and MDD were determined based on trends in the 
standardization samples used in development of the PAI (Morey, 1996). Three different 
samples were used when standardizing the PAI and included a community sample, 
patients from various clinical settings, and college students from several universities 
(Morey, 1991). Green, Lowry, and Kopta (2003) demonstrated significant differences in 
college students and college counseling center clients including level of well-being, life 
functioning, and global mental health. They found that adults not in treatment were the 
healthiest, followed in decreasing order by college students, college counseling center 





Morey (2007a) are not necessarily generalizable to university counseling center clients. 
Furthermore, Morey (1996) suggested that cross-validational research be conducted on 
the DCC’s since they are based on the standardization samples of the PAI. 
To date, no studies have examined the validity of the PAI’s DCC’s for MDD and 
GAD. Furthermore, the extant literature does not provide information regarding PAI 
scales/subscales that discriminate between a diagnosis of MDD and GAD. This study 
aims to address these gaps in the literature. The purpose of this study is four-fold: (1) To 
investigate the validity of the PAI’s DCC’s for MDD and GAD with university 
counseling center clients, (2) To determine which, if any, scales or subscales of the PAI 
discriminate between a diagnosis of MDD and GAD in university counseling center 
clients, (3) To contribute to the growing literature on the use of the PAI as a diagnostic 
tool, and (4) to provide information to university counseling center professionals that 





CHAPTER II: LITERATURE REVIEW 
 
Major Depressive Disorder 
Major Depressive Disorder (MDD) (APA, 2000) is a frequently occurring 
psychological disorder that causes varying levels of clinically significant distress (see 
Appendix A for the diagnostic criteria for MDD). Estimates of community samples have 
reported lifetime risk for MDD of 10% to 25% for women and 5% to 12% for men. The 
prevalence rates for MDD do not appear to be related to ethnicity, education, income, or 
marital status (APA, 2000). MDD has been shown to have significant biological/genetic 
components, and studies have demonstrated that it is 1.5 to 3.0 times as common among 
first-degree relatives of individuals with the disorder compared to the general population 
(APA, 2000). The most negative outcome of MDD is suicide, which is estimated to occur 
in as many as 15% of individuals who have the severe form of the disorder (APA, 2000). 
The course of MDD is characterized by one or more Major Depressive Episodes. 
The rate of recurrence is widely variable, and some individuals will have isolated 
episodes that are several years apart, while others experience progressively more frequent 
episodes as they age (APA, 2000). Studies have shown that with each additional episode 
that occurs, the risk for future episodes is increased to the degree that having three 
episodes leads to a 90% chance of having a fourth (APA, 2000). Episodes are often 
preceded by a major psychosocial stressor, and studies have suggested that these stressors 
may have a more significant impact on the first or second episodes, and less of an 





Generalized Anxiety Disorder 
Generalized Anxiety Disorder (GAD) (APA, 2000) is a commonly occurring 
psychological disorder that is characterized by excessive anxiety and worry that cause 
clinically significant distress (see Appendix B for the diagnostic criteria for GAD). 
Estimates of community samples have reported the lifetime prevalence rate to be 5% 
(APA, 2000). GAD has been shown to have significant biological/genetic components. In 
particular, the genetic factors that appear to play a role in the risk for GAD may be 
intimately connected to those for MDD (APA, 2000). 
The course of GAD is chronic and variable with stressful times often worsening 
the disorder (APA, 2000). Several individuals diagnosed with GAD report that they have 
experienced nervousness and anxiety their entire life (APA, 2000). More than half of 
those who seek treatment for GAD report onset in childhood or adolescence, although it 
is not uncommon for onset to occur after age twenty (APA, 2000). 
Differential Diagnosis of MDD and GAD 
Both MDD and GAD frequently co-occur with several other psychiatric disorders, 
and in particular, the two often co-exist (APA, 2000). Additionally, the associated 
symptom criteria for MDD and GAD have significant overlap, which complicates 
differential diagnosis of the two disorders. In particular, four of the six physical symptom 
criteria of GAD – restlessness, fatigue, difficulty concentrating, and sleep disturbance – 
are also part of the diagnostic criteria for MDD (APA, 2000). Indeed, Brown et al. (1995) 





significantly discriminate patients with GAD from those with MDD or Dysthymic 
Disorder. Despite the diagnostic symptom overlap, studies have found differences in the 
physical presentation of MDD and GAD. For instance, Joorman and Stoeber (1999) 
found that difficulty concentrating was more powerfully linked to depressive symptoms 
than to worry. Additionally, Aldao, Mennin, Linardtos, and Fresco (2010) demonstrated 
that muscle tension was experienced to a greater degree in GAD than MDD. 
MDD and GAD also have cognitive symptom criteria that overlap; however, 
recent studies have revealed that there are certain aspects of cognition that appear to 
manifest differently in MDD and GAD. In particular, intolerance of uncertainty, a 
measure of the degree to which an individual believes that uncertainty is not acceptable, 
has been shown to have greater elevations in GAD compared to MDD (Dugas, Buhr, & 
Ladouceur, 2004; Dugas, Schwartz, & Francis, 2004). 
Affective experience is another realm that has been studied in MDD and GAD. 
Again, although there are emotional symptoms that overlap in the two disorders, studies 
have uncovered differences in particular aspects of emotional expression between MDD 
and GAD. Specifically, the construct of emotion intensity, which is defined to be the 
subjective strength of an emotional response, has demonstrated elevated levels in GAD 
(Mennin, Heimberg, Turk, & Fresco, 2005). Furthermore, more recent research has found 
emotion intensity to be greater in GAD than Depressive disorders (Kerns, Aldao, & 





Another characteristic of emotional expression that has shown differences of 
expression in MDD and GAD is the construct of positive affect, which is conceptualized 
as a measure of the extent to which a person feels enthusiastic, active, and alert. 
Consequently, low positive affect is manifested as decreased arousal, activity, and energy 
(Beck et al., 2001). Aldao et al. (2010) found that reduced positive affect was associated 
with MDD, while individuals with a diagnosis of GAD demonstrated normal levels of 
positive affect. 
Diagnostic Consideration Clusters 
The PAI Structural Summary-Revised (Morey, 2007a) was created to provide 
clinicians with a means of integrating information from a PAI protocol that could be used 
to facilitate the process of interpretation and case formulation (Morey & Hopwood, 
2007). The Structural Summary-Revised is comprised of four sections including: (1) 
Profile Distortion Analysis, (2) Diagnostic Consideration Clusters, (3) Self/Other Issue 
Clusters, and (4) Differential Treatment Indicators (Morey, 2007a). Of particular interest 
to the present study is the second section, Diagnostic Consideration Clusters (DCC). 
The DCC’s are intended to serve the clinician by guiding them in the formation 
and testing of diagnostic hypotheses (Morey & Hopwood, 2007). The Structural 
Summary-Revised contains DCC’s for 33 specific disorders that correspond with DSM-
IV-TR diagnoses (APA, 2000). The DCC’s are separated into the following seven 
categories: (1) Affective Disorders, (2) Anxiety Disorders, (3) Psychotic Disorders, (4) 





Other Diagnoses (Morey, 2007a). The range of disorders covered by the DCC’s includes 
“No Diagnosis” and Dissociative Identity Disorder (Morey, 2007a). In addition to using 
the DCC’s to determine the presence of specific disorders, Morey and Hopwood (2007) 
suggest that the DCC’s can be useful for differential diagnosis. 
Each DCC contains a cluster of scales/subscales that are typically elevated or 
suppressed in the presence of a particular diagnosis (Morey & Hopwood, 2007). 
Importantly, the determination of elevation and suppression is made within the context of 
the profile rather than simply being based on a particular cutoff score. Morey and 
Hopwood (2007) suggest using the Mean Clinical Elevation (MCE) as a reference point 
for making this determination. The MCE is the average T score from all 11 clinical 
scales; therefore, if a profile has a MCE of 70T, then a scale/subscale score of 60T would 
be considered a relative suppression despite the fact that it is elevated relative to the 
community norms of the PAI scales/subscales, which are represented by 50T (Morey, 
1991). The selection of scales/subscales for the DCC’s was based on the constructs that 
individual scales/subscales were designed to measure (Morey, 1991), and on the results 
of studies that have examined specific diagnostic groups for typical scale/subscale 
elevations (Morey & Hopwood, 2007). Of particular interest in the present study are the 
DCC’s for MDD and GAD. 
The DCC’s for GAD and MDD were determined based on trends in the 
standardization samples used in the development of the PAI (Morey, 1996). Three 





sample, patients from various clinical settings, and college students from several 
universities (Morey, 1991). Appendix D contains a description of the DCC’s for MDD 
and GAD, including which scales/subscales are expected to be elevated or suppressed. 
Morey and Hopwood (2007) propose that individuals with a diagnosis of MDD 
will typically demonstrate elevations of all three DEP subscales and the SUI scale. 
Additionally, the authors note that the presence of low self-esteem (MAN-G), social 
withdrawal (SCZ-S) and cognitive inefficiency (SCZ-T), which are often seen in MDD, 
will significantly impact these subscales. Consequently, the DCC for MDD contains 
DEP-A, DEP-P, DEP-C, SUI, SCZ-T, and SCZ-S as relative elevations, and MAN-G as a 
relative suppression. 
Morey (2003) suggests that an elevation on the ANX-A subscale, without 
corresponding elevations on the other two ANX subscales, is suggestive of generalized 
anxiety as opposed to more specific worries such as obsessive thoughts, phobias, or 
preoccupation with somatic concerns. Accordingly, the DCC for GAD includes the 
ANX-A subscale as a relative elevation, but does not contain the other two ANX 
subscales. Furthermore, Morey and Hopwood (2007) suggest that an elevation on ANX 
in the absence of elevations on ARD and DEP is indicative of a diagnosis of GAD. 
Again, this is consistent with the DCC for GAD which contains ANX as a relative 





CHAPTER III: MATERIALS AND METHODS 
 
Overview 
An archival data set from a counseling center at a large southeastern university 
was used to obtain the data for this study. Specifically, these data were collected during 
the period of October 2005 to June 2009 from university students who were receiving 
psychological services at the counseling center. Prior to inclusion in the research archive, 
each client consented to have their non-identifying data archived for future research. As 
an archival study, this study was approved by the university’s Institutional Review Board 
(IRB). 
Counseling Center Description 
The counseling center provides undergraduate and graduate students of the 
university with free individual, couples, and group therapy. Students initially come to the 
center during walk-in hours and complete a packet of information that includes 
demographic information, current symptoms and concerns, available times for therapy, 
and information regarding confidentiality and the therapy process. The paperwork 
contains an informed consent form regarding the archival of their de-identified data for 
research purposes. Clients who consent to the inclusion of their records in the archival 
data set are assigned a research identification number that helps to ensure their anonymity 
and confidentiality, while still allowing for future matching of various forms of client 





that were either incomplete or completed incorrectly were excluded from use in this 
study. 
The therapists at the counseling center include 10 licensed psychologists, 4 pre-
doctoral psychology interns, and 3 graduate assistants and 5 to 16 practicum students who 
are doctoral students in counseling or clinical Psychology. Each of the therapists has been 
trained in generating accurate differential diagnoses. Additionally, for those therapists 
who are still in training, a licensed psychologist supervises their work and reviews the 
diagnoses they generate to ensure their accuracy and thoroughness. Following the first 
and fifth sessions of therapy, and again when therapy is terminated, therapists make a 
full, five-axis DSM-IV-TR (APA, 2000) diagnosis. 
Participants 
Participants were 1541 students who received services at the student counseling 
center at a large southeastern university during the period of October 2005 to June 2009. 
The mean age of the sample was 22.42 (SD = 5.15; range 18 - 59), and included 1052 
females (68.5%) and 483 males (31.5%). Six participants did not report their gender. 
There were 683 participants (44.3%) who either did not report their race/ethnicity, or the 
information had not been recorded. Self-identified racial/ethnic data were available for 
858 participants (55.7%) and included 722 (84.1%) White/Caucasian/European 
American, 71 (8.3%) African American/Black, 25 (2.9%) Asian/Asian American, 13 
(1.5%) Other, 11 (1.3%) Hispanic/Latino/a, 8 (0.9%) Multiracial, 5 (0.6%) Arab 





The sample used in this study is very similar with respect to age and gender, but 
somewhat dissimilar in racial/ethnic configuration, to the population in the 2009 CSCMH 
pilot study (Locke, 2009) which had a mean age of 22.7 (SD = 5.38; range 18 – 80), a 
composition of 64.3% females and 35.4% males, and racial/ethnic configuration of 
70.4% White/Caucasian/European American, 7.7% African American/Black, 6.2% 
Asian/Asian American, 2.5% Other, 5.8% Hispanic/Latino/a, 3.2% Multiracial, 0.5% 
Arab American, 0.4% American Indian/Alaskan Native, 0.6% East Indian, 0.3% Native 
Hawaiian or Pacific Islander, and 2.4% who preferred not to answer. 
Participants were separated into three categories: (1) those who had received a 
diagnosis of MDD with no co-morbid Axis I disorder (n = 135), (2) those who had 
received a diagnosis of GAD with no co-morbid Axis I disorder (n = 79), and (3) those 
who had received any diagnosis other than the two just described, which could include a 
diagnosis of MDD and/or GAD with one or more co-morbid Axis I disorder(s) (n = 
1327). The three categories described above will be referred to hereafter as MDD, GAD, 
and OD (Other Diagnosis) respectively. 
The choice to restrict participants diagnosed with co-morbid Axis I disorders from 
the MDD and GAD categories was based upon the belief that the presence of additional 
Axis I disorders would significantly impact the profile configuration on the PAI. This 
assumption was based on both the conceptual design of the PAI clinical scales (Morey, 
1991) and the findings from previous studies. In particular, Drury et al. (2009) found 





a single Axis I diagnosis of posttraumatic stress disorder (PTSD) to women diagnosed 
with PTSD and one or more additional Axis I disorders. The authors concluded that the 
clinical profile elevation of the PAI is clearly impacted by the co-morbidity of psychiatric 
illnesses. Therefore, in an attempt to create the most representative PAI profiles for MDD 
and GAD, this study placed participants with co-morbid Axis I disorders in the OD 
category. 
Instrument 
The PAI is a self-administered, objective inventory of adult personality that 
provides information on important clinical variables (Morey, 1991). It contains 344 items 
that consist of 22 non-overlapping full scales. Additionally, 10 of the full scales contain 3 
or 4 subscales that are conceptually derived to cover the full breadth of their 
corresponding complex clinical constructs. The full scales are grouped into the following 
four categories: validity, clinical, treatment, and interpersonal. The four validity scales 
include Inconsistency (ICN), Infrequency (INF), Negative Impression (NIM), and 
Positive Impression (PIM). See Appendix C for a description of the clinical, treatment, 
and interpersonal scales/subscales. The scale/subscale raw scores are transformed into T 
scores to allow for interpretation relative to the standardization sample of 1000 
community-dwelling adults. Each scale/subscale has a mean of 50T and a standard 
deviation of 10T. A scale/subscale score of 70T, two standard deviations above the mean, 
represents a significant deviation from the typical adult living in the community given 





such, Morey (1991) suggests that scale/subscale scores of 70T or higher represent 
clinically significant problem areas. To view examples of PAI profiles, go to Appendix E 
which contains separate graphs for the full scales and subscales, including horizontal 
lines at 50T and 70T to represent the mean and clinically significant levels respectively. 
The PAI was developed based upon a construct validation framework that utilized 
both rational and empirical approaches to scale development. This method strongly 
emphasizes scale stability and correlates, and places importance on the use of both 
theoretical and quantitative items. Morey (1991) found the internal consistency reliability 
of the PAI full scales to have median coefficient alphas of .81, .86, and .82 for the 
normative, clinical, and college samples respectively. Additionally, the mean interitem 
correlations for the full scales were .22, .29, and .21 for the three respective samples. The 
mean test-retest reliability for the full scales of the various PAI samples ranged from .75 
to .79. The PAI has been well validated for several treatment populations (Morey, 
2007b), and various PAI scales have correlated well with scales of several other 
frequently used personality and diagnostic instruments that measure similar constructs 
(Morey, 1991). 
Procedure 
For the purposes of this study, the fifth session diagnosis was determined to be the 
most appropriate based on a number of considerations. First, given that the PAI is 
administered prior to the first session of therapy, it is important to use a diagnosis that is 





under the supposition that additional client contact yields increased diagnostic accuracy, 
the diagnosis following the fifth session should be more precise than one following the 
first session. For those clients who attended less than five sessions, their diagnosis 
following termination was used based upon the same reasoning noted above. Diagnostic 
qualifiers were taken into consideration and only diagnoses without a qualifier or with a 
“principle” qualifier were selected for the MDD and GAD groups. Diagnoses with 
qualifiers of “provisional”, “traits”, or “rule out” were not placed in the MDD or GAD 
groups given the uncertainty of the diagnosis. Additionally, diagnoses of MDD with no 
co-morbid Axis I disorder that had a specifier of either partial or full remission were not 
included in the MDD group. It is possible that the therapist’s diagnostic decisions were 
influenced by reviewing the results of the PAI prior to making their diagnosis. Although 
the PAI results do provide interpretive hypotheses regarding diagnosis, they are merely 
suggestions, and the clinician is still expected to consider all possible diagnoses that are 
applicable to a given client. 
Titanium Schedule was used to generate a report that contained diagnostic and 
demographic information for clients who had consented to the inclusion of their records 
in the archival data set. The report also provided the research identification numbers that 
were then used to match diagnostic and demographic information with PAI data that were 
only identifiable by the associated research identification numbers. These data were 







Data analysis began by assessing the validity of each participant’s PAI profile, 
which was determined using the following cutoff scores suggested by Morey (1991) for 
the four validity scales: ICN >= 73T, INF >= 75T, NIM >= 92T, and PIM >= 68T. Every 
PAI profile that exceeded one or more of these scale scores was considered invalid. This 
process led to the removal of 79 participants from the study including eight from the 
MDD group, four from the GAD group, and 67 from the OD group. 
The remaining data were then used to calculate mean PAI profiles for the entire 
sample, the MDD group, the GAD group, and the OD group. Next, the mean clinical 
elevation (MCE) was computed for each participant using the method described by 
Morey and Hopwood (2007), which entails summing the T scores of the 11 clinical scales 
and then dividing the sum by 11. The MCE for each participant was used to calculate a 
mean MCE for the entire sample, the MDD group, and the GAD group. Each 
participant’s MCE was then used to evaluate their scores on the scales/subscales of the 
DCC’s for MDD and GAD (Morey, 2007a). As suggested by Morey (2007b), a 
scale/subscale was determined to be relatively elevated or suppressed if it had a T score 
that was more than 5 above or below the MCE, respectively. These results were then used 
to compute the percentage of participants in each of the three diagnostic groups (MDD, 
GAD, and OD) that exhibited the relative elevations and suppressions of the DCC’s for 





Data analysis concluded by performing three discriminant analyses (DA) to 
determine the linear combination of scales/subscales of the PAI which most accurately 
discriminated between each pair of the three diagnostic groups: (1) MDD from OD, (2) 
GAD from OD, and (3) MDD from GAD. DA is useful for several purposes including, 
examining differences between groups, determining the most parsimonious way to 
distinguish between groups by discarding variables that are not very useful for the task, 
and classifying individual cases into groups using a discriminant prediction equation. The 
current study used DA to create discriminant functions capable of predicting between two 
diagnostic groups with the aim of incorporating as few scales/subscales as possible. 
To achieve the above mentioned goal, the decision was made to use the stepwise 
method of DA given the nature of the data. Specifically, 9 of the 11 clinical scales and 1 
of the 5 treatment scales of the PAI are comprised of 3 subscales (with the exception of 
the BOR scale which contains 4 subscales). Each of these 10 full scales is calculated by 
summing the raw scores of the respective subscales, and then converting the result into an 
appropriate T score (Morey, 1991). As such, there are high levels of correlation between 
these full scales and each of their subscales. Additionally, many (although not all) 
subscales are highly correlated with the other subscales associated with the same full 
scale (e.g., DEP-C and DEP-A). This is due to the fact that they measure specific 
constructs within the same general construct domain (Morey, 1991). Given the 





the stepwise method of DA to achieve the goal of fewest scales/subscales being used in 
the discriminant functions. 
The stepwise procedure works by first selecting the most highly correlated 
independent variable (in the case of this study, a PAI scale/subscale), removing the 
variance in the dependent variable (in the case of this study, diagnosis), then selecting the 
independent variable (another PAI scale/subscale) that is most highly correlated with the 
remaining variance in the dependent variable. This process continues until the addition of 
another independent variable does not increase the canonical R-squared value by a 
significant amount (.05 was established as the significance level in this study). Thus, an 
independent variable that is highly correlated with one that has already been selected is 
unlikely to be added due to the lack of additional discriminatory power. This impacts the 
current study in that the resultant discriminant function is unlikely to contain multiple 
scales/subscales from the same domain (e.g., DEP and DEP-P). Although a particular 
domain may, and often does, contain two or more scales/subscales with significantly 
different mean T scores between the two diagnostic groups being considered, only the 
scale/subscale that provides the greatest differentiation between groups is likely to be 
selected. Therefore, the stepwise procedure facilitates the creation of the most 
parsimonious discriminant function, which was the goal in the present study. 
Hypotheses 
It was hypothesized that the results of this study would confirm the validity of the 





on the DCC for MDD (Morey, 2007a) and the mean PAI profile for MDD (Morey, 1991), 
it was hypothesized that the following scales and subscale would be found to discriminate 
between the MDD and OD diagnostic groups: (1) DEP, (2) SUI, and (3) MAN-G. Morey 
(1991) does not provide a mean PAI profile for GAD; however, he suggests that an 
elevation on the ANX-A subscale, without corresponding elevations on the other two 
ANX subscales, is suggestive of generalized anxiety as opposed to more specific worries 
such as obsessive thoughts, phobias, or preoccupation with somatic concerns (Morey, 
2003). Thus, based on the DCC for GAD (Morey, 2007a) and the recommended use of 
the ANX subscales to identify general forms of anxiety (Morey, 2003), it was 
hypothesized that (1) the ANX-A subscale and (2) the SCZ full scale would be found to 
discriminate between the GAD and OD diagnostic groups. Finally, based on the DCC’s 
for MDD and GAD (Morey, 2007a), the mean PAI profile for MDD (Morey, 1991), and 
the aforementioned use of the ANX subscales (Morey, 2003), it was hypothesized that 
the following scale/subscales would be capable of discriminating between the MDD and 






CHAPTER IV: RESULTS 
 
PAI Profiles 
Various graphs of the mean PAI full scale and subscale elevations for MDD, 
GAD, OD, and the entire sample can be found in Appendix E. The available graphs 
include: (1) separate graphs (full scale and subscale) for the entire sample, (2) separate 
graphs for MDD, including representations of the mean MCE and its elevation and 
suppression boundaries, (3) separate graphs for GAD, including representations of the 
mean MCE and its elevation and suppression boundaries, (4) graphs comparing MDD, 
GAD, and the entire sample, (5) graphs comparing MDD and OD, (6) graphs comparing 
GAD and OD, and (7) graphs comparing MDD and GAD. Appendix F contains 
numerical values for the means and standard deviations of the PAI full scale and subscale 
T scores for MDD, GAD, OD, and the entire sample. 
Mean Clinical Elevations 
The mean MCE for the entire sample was 56.36T (SD = 7.67; range 32.91 – 
84.82; N = 1541). The mean MCE for the MDD group was 57.60T (SD = 6.12; range 
46.45 – 74.82; n = 135). Finally, the mean MCE for the GAD group was 55.54T (SD = 
6.06; range 42.25 – 78.91; n = 79). 
Diagnostic Consideration Clusters 
Calculations were performed to determine the percentage of participants in each 
of the three diagnostic groups (MDD, GAD, and OD) that matched every scale/subscale 





conducted to find the percentage of participants in each of the three diagnostic groups 
that matched each individual scale/subscale elevation and suppression for the MDD and 
GAD DCC’s. The results of these calculations can be found in Appendix G. 
Discriminant Analyses 
DA’s were performed on all pairs of the three diagnostic groups: (1) MDD and 
OD, (2) GAD and OD, and (3) MDD and GAD. For reasons previously explained, the 
stepwise method of DA was used. When the stepwise procedure is employed, it is 
recommended that cross-validation be utilized to confirm the results of the DA. Each of 
the three DA’s were cross-validated using the jack-knife procedure. In each case, the 
results of the cross-validation procedure confirmed the appropriateness and accuracy of 
the stepwise procedure. 
The first DA was conducted to determine which PAI scales/subscales 
discriminated between a diagnosis of MDD and OD. The overall Wilks’ Lambda was 
significant, Λ = .907, χ2 (4, n = 1462) = 141.76, p < .001, indicating that the discriminant 
function differentiated between the two diagnostic groups. The canonical correlation was 
.304, which reveals that 9.2% of the variation between the two diagnostic groups was 
discriminated by the selected scales/subscales. Diagnostic category was predicted using 
four PAI scales/subscales, listed in decreasing order of significance: (1) DEP, (2) ANX, 
(3) SUI, and (4) ANT-E. Pooled within-groups correlations between the predictors and 
the discriminant function, and the standardized discriminant function coefficient for each 





membership, classification was successful in 68.1% of the MDD group, and 74.0% of the 
OD group. Of the original grouped cases, 73.5% were correctly classified. 
Next, a DA was run to determine which PAI scales/subscales discriminated 
between a diagnosis of GAD and OD. The overall Wilks’ Lambda was significant, Λ = 
.899, χ2 (3, n = 1406) = 149.41, p < .001, indicating that the discriminant function 
differentiated between the two diagnostic groups. The canonical correlation was .318, 
which reveals that 10.1% of the variation between the two diagnostic groups was 
discriminated by the selected scales/subscales. Diagnostic category was predicted using 
three PAI subscales, listed in decreasing order of significance: (1) ANX-C, (2) BOR-I, 
and (3) DEP-A. Pooled within-groups correlations between the predictors and the 
discriminant function, and the standardized discriminant function coefficient for each 
predictor are presented together in Appendix I. When attempting to predict group 
membership, classification was successful in 82.3% of the GAD group, and 77.2% of the 
OD group. Of the original grouped cases, 77.5% were correctly classified. 
Finally, a DA was performed to determine which PAI scales/subscales 
discriminated between a diagnosis of MDD and GAD. The overall Wilks’ Lambda was 
significant, Λ = .412, χ2 (6, n = 214) = 185.55, p < .001, indicating that the discriminant 
function differentiated between the two diagnostic groups. The canonical correlation was 
.767, which reveals that 58.8% of the variation between the two diagnostic groups was 
discriminated by the selected scales/subscales. Diagnostic category was predicted using 





(3) BOR-S, (4) SCZ-P, (5) SOM-S, and (6) MAN-G. Pooled within-groups correlations 
between the predictors and the discriminant function, and the standardized discriminant 
function coefficient for each predictor are presented together in Appendix J. When 
attempting to predict group membership, classification was successful in 93.3% of the 






CHAPTER V: DISCUSSION 
 
Diagnostic Consideration Cluster for MDD 
It was hypothesized that the DCC for MDD would be shown to be valid when 
used with university counseling center clients. In stark contrast to this expectation, the 
results indicated that only 2.2% of the participants in the MDD group demonstrated all of 
the scale/subscale elevations and suppressions (see Appendix G for complete results of 
the DCC analyses); therefore, I decided to examine each of the seven scales/subscales 
individually. One possible reason for the extremely low hit rate was that one or more of 
the scales/subscales were not valid. In such a scenario, it was possible for all of the other 
scales/subscales to be valid, but since the initial computation required all seven to be 
valid, having even one invalid scale/subscale would likely cause a “miss” for a large 
majority of the group members, and thus account for the final result being lower than 
anticipated. 
Based upon the aforementioned possibility, I evaluated each scale/subscale 
individually. The results showed that three subscales – DEP-A, DEP-C, MAN-G – had 
hit rates greater than 70%, which suggests that they are reasonably valid for the purpose 
of detecting the presence of MDD in university counseling center clients. The remaining 
four scales/subscales – SCZ-S, SUI, DEP-P, SCZ-T – had hit rates between 37% and 
57%. It could reasonably be argued that these four scales/subscales are not valid for use 
in detecting the presence of MDD. Although the lowest individual scale/subscale hit rate 





rates near or below 50% likely accounts for the extremely low hit rate of 2.2% when 
every scale/subscale in aggregate was required to meet criteria. Taken together, these 
results indicate the DCC for MDD is not recommended for detecting the presence of 
MDD with the population sampled in this study. 
When the graphs containing the mean PAI full scale and subscale elevations for 
the MDD group are examined in Appendix E, it is possible to visualize why the 
preceding results were obtained. The graphs contain a solid yellow line that represents the 
mean MCE for the MDD group, and two dashed yellow lines above and below the mean 
MCE line that represent the boundaries for relative elevation and suppression. As shown 
in the MDD subscale graph, the mean elevations for DEP-A and DEP-C are a 
considerable distance above the cutoff for relative elevation. Accordingly, each subscale 
demonstrated a hit rate in the 80% range. Similarly, the mean elevation for the MAN-G 
subscale is a moderate distance below the relative suppression, and had a hit rate close to 
70%. Three of the four remaining scales/subscales – SUI, DEP-P, SCZ-T – have mean 
elevations that are only slightly above the cutoff for relative elevation and exhibit hit 
rates near 50%. Finally, SCZ-S is actually below the cutoff for relative elevation and 
showed a hit rate near 37%. 
It is reasonable that a scale/subscale that is at or very near the relevant cutoff for 
relative elevation or suppression would have a hit rate near 50%. Based on the 
assumption that the T scores for each scale/subscale are normally distributed within a 





the cutoff for its corresponding relative elevation or suppression would have half of the 
group members above and half of them below the cutoff, and thus a near 50% hit rate. 
Using the same reasoning, it is realistic to expect that a group with a mean scale/subscale 
elevation that is less than the cutoff for its corresponding relative elevation or more than 
the cutoff for its corresponding relative suppression would have a hit rate below 50%. 
The hit rate of 48.1% for DEP-P was unexpected. It is important to keep in mind 
that the hit rate is based on the MCE, and thus an extremely large MCE could account for 
such a low hit rate; however, in the case of the MDD group, the mean MCE was 57.60T, 
which is less than one standard deviation above the community norm of 50T. In fact, as 
seen in Appendix F, the mean elevation on the DEP-P subscale for the MDD group was 
63.60T, which is less than the level of clinical significance. The other two DEP subscales, 
DEP-C and DEP-A, each had mean elevations that were clinically significant. 
The DEP-P subscale measures constructs such as physical functioning, energy, 
and activity, as well as level of sleep pattern disturbance (Morey, 1991). One possible 
explanation for the current findings is that university counseling center clients experience 
fewer physiological symptoms of MDD than cognitive and affective symptoms. 
However, the results obtained here are consistent with those found by Morey (1991) in 
his sample of MDD patients which also demonstrated clinically significant elevations for 
DEP-C and DEP-A, but not for DEP-P (Regarding the comparisons to the MDD sample 
used by Morey, it is interesting to note that the present study had a greater number of 





126)). This suggests that university counseling center clients are similar to Morey’s 
clinical populations in their presentation of MDD. More likely, the consistent results 
regarding the DEP-P subscale indicate that either it does not accurately measure the 
construct it is designed to assess, or patients diagnosed with MDD indicate more 
cognitive and affective symptoms than physiological symptoms. Future research could 
examine the DEP subscales with patients who exhibit more prominent physiological 
symptoms of depression as a means of assessing the accuracy of the DEP-P scale. 
The SCZ-T subscale had a hit rate of 56.3% and mean elevation of 66.12T for the 
MDD group. SCZ-T is designed to measure thought processes that are marked by 
confusion and difficulty concentrating (Morey, 1991). Interestingly, these are similar to 
one of the cognitive symptoms of MDD (APA, 2000). As such, it is somewhat surprising 
that the DEP-C subscale, which measures the cognitive aspects of depression, was 
clinically significant and yet the SCZ-T scale was not. Perhaps one explanation for this 
finding is that the given the intent of the SCZ-T subscale to measure particular aspects of 
Schizophrenia, the degree to which MDD patients experience the symptoms measured by 
SCZ-T is not as high as patients with Schizophrenia, and thus did not reach the level of 
clinical significance. Similar to DEP-C, DEP-A, and DEP-P, the results obtained here for 
SCZ-T are consistent with those found by Morey (1991) in his sample of MDD. This 
provides additional evidence to suggest that university counseling center clients are 





Another surprising result was that SCZ-S had a hit rate of only 37.8% and a mean 
elevation of 59.08T, which was less than 2T above the mean MCE for the MDD group. 
SCZ-S is designed to measure social isolation and amount of interpersonal relationships 
that could be described as close and warm (Morey, 1991). One possible explanation for 
the current findings is that at the point university students with MDD typically present for 
treatment they may not have begun to isolate themselves from their friends as a result of 
being depressed. Anecdotal evidence has shown that often university counseling center 
clients are experiencing their first episode of major depression, and are thus confused and 
startled by what is occurring, which leads them to seek treatment earlier in the process. 
Another potential reason for these findings is that the environment of a university is such 
that students will typically be around several others throughout their day as they attend 
classes, live in a dorm, eat meals, etc. From a clinical standpoint, students with MDD 
may be deemed to be isolating themselves and feeling they do not have close 
relationships, but the content of the items for SCZ-S may be such that university students 
with MDD do not endorse these items as a result of their environment. 
The fourth and final scale of the DCC for MDD that was determined to be invalid 
for detecting MDD in university counseling center clients was the SUI scale which had a 
hit rate of 45.2% and mean elevation of 64.20T. The results obtained here are in stark 
contrast to those obtained by Morey (1991) in his sample of patients with MDD which 
showed a mean elevation that was well above the cutoff for clinical significance. One 





receiving inpatient treatment. As such, it is reasonable to expect that the mean elevation 
on the SUI scale would be higher in that sample than the one used for the current study. 
In fact, Morey (1991) states that the significant proportion of inpatients in the MDD 
sample likely increased the elevation on the SUI scale. 
Another possible explanation for the current finding is that university counseling 
center clients with MDD either do not express a clinically significant level of suicidal 
ideation, or they experience suicidal ideation to a lesser degree than the general 
population with MDD. This is unlikely given that the latest data from the American 
Association of Suicidology shows suicide to be the third highest cause of death among 
15-24 year-olds (McIntosh, 2010). Although the rate of suicide is slightly less for this age 
group than all ages combined, 9.7 versus 11.5 per 100,000 in the population (McIntosh, 
2010), this slight difference is unlikely to account for the results obtained in the present 
study. Additionally, suicide is the second leading cause of death among 20-24 year-olds, 
and the lifetime suicide rate peaks for this age group (Locke, 2009). Furthermore, the 
2009 CSCMH pilot study (Locke, 2009) found that 25% of university counseling center 
clients reported they had seriously considered suicide at some point in their life. One 
implication of the current finding is that when examining the SUI scale for university 
counseling center clients, clinicians should consider the possibility that the level of 
suicidality is clinically significant even if it is below 70T. 
As previously mentioned, Morey and Hopwood (2007) suggest that in addition to 





useful for differential diagnosis. Based on this assumption, it was decided a priori to 
examine the DCC for MDD using the GAD and OD groups, and compare these results 
with those for the MDD group as a means of inspecting the validity of the authors’ claim. 
Given the results of the analyses on the MDD group, these additional computations were 
unnecessary in that it was not possible for the DCC for MDD to be valid for differential 
diagnosis. Nevertheless, the results of the analyses with the GAD and OD groups 
revealed some rather startling results. 
Perhaps the most surprising result was that the GAD group exhibited a slightly 
higher hit rate than the MDD group on DEP-P. As noted previously, the DEP-P subscale 
measures constructs such as physical functioning, energy, and activity, as well as level of 
sleep pattern disturbance (Morey, 1991). These concepts have considerable overlap with 
the associated symptom criterion for GAD (APA, 2000). The results obtained here are 
consistent with those of Brown, Marten, and Barlow (1995) who found that the 
associated symptom criterion for GAD in the DSM-IV (APA, 1994) did not significantly 
discriminate patients with GAD from those with MDD or Dysthymic Disorder. One 
implication for the current findings is that the DEP-P subscale does not adequately 
differentiate between the somatic symptoms of MDD and GAD. In contrast, the other two 
DEP subscales, DEP-C and DEP-A, both had much higher hit rates for the MDD group 






Also unexpected were the results of the hit rates by each of the three diagnostic 
groups on the SCZ-T subscale. Specifically, all of the groups had hit rates between 53.1% 
and 56.3%, and mean elevations between 62.32T and 66.12T. As discussed previously, 
SCZ-T is designed to measure thought processes that are marked by confusion and 
difficulty concentrating (Morey, 1991). As with the aforementioned similarity of these 
constructs to a cognitive symptom of MDD, they are also related to one of the six 
criterion symptoms of GAD (APA, 2000). Given this, it is not surprising that the hit rates 
and mean elevations for the MDD and GAD groups were virtually identical. In contrast, 
the nearly matching hit rates and mean elevations for the MDD and OD groups seem 
improbable given the vast heterogeneity of diagnoses in the OD group. One implication 
of this finding is that regardless of diagnosis, university students who seek services at the 
counseling center are experiencing similar and somewhat elevated levels of thought 
disruption in the form of confusion and/or difficulty concentrating. 
Although the MAN-G subscale was shown to be fairly capable of detecting the 
presence of MDD, it does not appear useful for discriminating between MDD and GAD. 
The hit rates and mean elevations for the MDD and GAD groups on the MAN-G subscale 
were 70.4% and 64.6%, and 46.36T and 47.63T, respectively. The MAN-G subscale is 
designed to measure self-esteem and grandiose thoughts such as possessing special and 
unique talents that will lead to fortune and fame (Morey, 1991). Considering one of the 
nine criterion symptoms of MDD is feelings of worthlessness (APA, 2000), and 





express a sense of hopelessness, it is expected that the MAN-G subscale would be 
suppressed for the MDD group. One explanation for the similar suppression seen in the 
GAD group is that the tendency to worry about the future may impact the responses to 
the items in the MAN-G subscale that allude to a successful future. Finally, as with 
several of the other subscales already discussed, the mean elevation for MAN-G in the 
MDD group is consistent with the findings Morey (1991) obtained from his MDD 
sample. This lends further credence to the notion that university counseling center clients 
are similar to Morey’s clinical population in their presentation of MDD. 
Curiously, when the mean scale/subscale elevations are examined for the MDD 
sample used by Morey (1991), the choice regarding scales/subscales to include in the 
DCC for MDD is confusing. In particular, DEP-P and SCZ-T have mean elevations that 
place them very near the boundary for relative elevation, which as previously noted 
would likely yield a hit rate in the 50% range. This presumed result is consistent with 
those obtained in the present study for DEP-P and SCZ-T. Furthermore, the mean 
elevation for SCZ-S in the MDD sample used by Morey (1991) is below the boundary for 
relative elevation and would probably result in a hit rate well below 50% for reasons 
previously explained. Again, this assumed hit rate is consistent with the results obtained 
in the present study for SCZ-S. 
Beyond the three scales/subscales of the DCC for MDD that the present study 
found to be valid for the purpose of detecting the presence of MDD (DEP-C, DEP-A, and 





purpose in the MDD sample used by Morey (1991). As such, the DCC for MDD would 
have only four of seven scales/subscales that were valid, which leads to the conclusion 
that overall the DCC for MDD is not valid for use with the MDD sample used by Morey 
(1991). One implication of this presumed conclusion is that the previously discussed 
overall lack of validity demonstrated by the DCC for MDD with university counseling 
center clients is unlikely a result of significant differences in presentation of MDD with 
university counseling center clients. More importantly, the suggested conclusion calls 
into question the validity of all the DCC’s. Future research should focus on examining 
each of the DCC’s to make this determination. 
Diagnostic Consideration Cluster for GAD 
Similar to the DCC for MDD, it was hypothesized that the DCC for GAD would 
be shown to be valid when used with university counseling center clients. Consistent with 
the findings for the DCC for MDD, the results indicated that only 3.8% of the GAD 
group demonstrated all of the scale/subscale elevations and suppressions (see Appendix 
G for complete results of the DCC analyses). As this outcome was so deviant from my 
expectations, I decided to examine each of the four scales/subscales individually. The 
rationale for these additional analyses was the same as that described for the MDD DCC. 
The results of the individual scales/subscales showed that ANX and ANX-A had 
hit rates greater than 80%, and ARD and SCZ had hit rates below 27%. These findings 
suggest that ANX and ANX-A are valid for the purpose of detecting the presence of 





purpose. Although the hit rates for two of the individual scales were lower than any of the 
hit rates for the individual scales/subscales of the MDD DCC, the slightly higher hit rate 
for the overall GAD DCC (3.8% versus 2.2%) is most likely explained by the lower 
number of scales/subscales required to meet criteria (four versus seven). Taken together, 
these results indicate the DCC for GAD is not valid for detecting the presence of GAD 
with the population sampled in this study. 
When the graphs containing the mean PAI full scale and subscale elevations for 
the GAD group are examined in Appendix E, it is possible to visualize why the preceding 
results were obtained. The graphs contain a solid yellow line that represents the mean 
MCE for the GAD group, and two dashed yellow lines above and below the mean MCE 
line that represent the boundaries for relative elevation and suppression. As shown in the 
GAD scale and subscale graphs, the mean elevations for ANX and ANX-A are a 
considerable distance above the cutoff for relative elevation. Accordingly, each 
scale/subscale demonstrated a hit rate greater than 80%. SCZ and ARD are both above 
the cutoff for relative suppression and show low hit rates as a result. In fact, SCZ is 
nearly equal to the mean MCE for the GAD group, and ARD is actually above the mean 
MCE. The respective hit rates of 26.6% and 15.2% are consistent with this observation. 
The hit rate of 15.2% for ARD was in stark contrast to the hypothesized result. It 
is important to keep in mind that the hit rate is based on the MCE, and thus an extremely 
small MCE could account for such a low hit rate when determining relative suppression; 





community norm of 50T. In fact, as can be seen in Appendix F, the mean elevation on the 
ARD scale for the GAD group was 59.20T, which is above the mean MCE. This result is 
surprising because it shows that not only is the ARD scale not relatively suppressed as 
suggested by the DCC for GAD, but also it is actually elevated relative to the mean MCE. 
Furthermore, the ARD scale showed the third highest mean elevation of all the full scales 
for the GAD group, lower only than the ANX and DEP scales. 
The ARD scale measures constructs related to three different areas of anxiety 
disorders: (1) fears associated with specific phobias, (2) thoughts and behaviors of an 
obsessive-compulsive nature, and (3) troublesome occurrences related to a traumatic 
event (Morey, 1991). Although the mean elevation for ARD was not clinically 
significant, it was raised compared to the community norm of 50T. Morey (1991) 
suggests that an ARD score in the range seen here is indicative of an individual who has 
little self-confidence and may have some specific fears or worries. The lack of self-
confidence is consistent with the finding previously noted for the MAN-G subscale which 
was relatively suppressed for the GAD group. Another possible explanation for the 
results obtained in the present study is that the specific item content of the ARD scale 
may contain fears or worries that are part of an individual’s pattern of generalized worry 
associated with GAD, thus they endorse those particular items, which leads to an elevated 
score on the ARD scale. Unfortunately, Morey (1991) does not provide mean 
scale/subscale elevations for a sample of patients diagnosed with GAD as he did for a 





comparisons between the MDD group in the present study and the MDD sample used by 
Morey (1991) cannot be made with the GAD group. 
The SCZ scale had a hit rate of 26.6% and mean elevation of 55.33T for the GAD 
group. This result was surprising because not only is the ARD scale not relatively 
suppressed as suggested by the DCC for GAD, but also it is actually nearly equal to the 
mean MCE of 55.54T. Although the mean elevation for SCZ was not clinically 
significant, it was raised compared to the community norm of 50T. 
SCZ is designed to measure several aspects of Schizophrenia including unusual 
beliefs and perceptions, social anhedonia and lack of social competence, and difficulties 
related to concentration, attention, and associational processes (Morey, 1991). The 
difficulty with concentration and attention is consistent with the finding previously noted 
for the SCZ-T subscale which was elevated relative to the mean MCE for the GAD 
group. Also, as explained earlier, these symptoms are related to the criterion symptoms of 
GAD (APA, 2000), and thus an elevation on SCZ-T is not surprising. When the other 
SCZ subscales are examined for the GAD group, we find that SCZ-P and SCZ-S have 
mean elevations of 45.76T and 53.09T, respectively. Again, these results are consistent 
with expectations for an individual diagnosed with GAD, who would be presumed to 
have no psychotic symptoms and exhibit fairly normal social functioning. Given the 
elevation on SCZ-T, nearly normal elevation on SCZ-S, and the suppression on SCZ-P, it 
is understandable that the full scale score for SCZ, which is calculated from these three 





As previously mentioned, Morey and Hopwood (2007) suggest that in addition to 
using the DCC’s to detect the presence of certain psychological disorders, they can be 
useful for differential diagnosis. Based on this assumption, it was decided a priori to 
examine the DCC for GAD using the MDD and OD groups, and compare these results 
with those for the GAD group as a means of inspecting the validity of the authors’ claim. 
Given the results of the analyses on the GAD group, these additional computations were 
unnecessary because it was not possible for the DCC for GAD to be valid for differential 
diagnosis. Nevertheless, the results of the analyses with the MDD and OD groups 
revealed some interesting results. 
Perhaps most surprising, the GAD group exhibited a much lower hit rate (15.2%) 
than the MDD and OD groups (34.1% and 26.8%) on ARD.  The mean scale elevations 
for GAD, MDD, and OD were 59.20T, 56.87T, and 57.27T. Given that the DCC for GAD 
expects ARD to be relatively suppressed, it is unexpected that not only is this not the 
case, but also it has the highest mean elevation of all three diagnostic groups. 
As noted above, the ARD scale is designed to measure constructs related to three 
different areas of anxiety disorders: (1) fears associated with specific phobias, (2) 
thoughts and behaviors of an obsessive-compulsive nature, and (3) troublesome 
occurrences related to a traumatic event (Morey, 1991). Potential explanations for the 
elevation seen with the GAD group were described above. One possible reason for the 
lower mean elevations of the MDD and OD groups can be drawn from an examination of 





than the MDD and OD groups on the ARD-P subscale (59.92T, 53.99T, and 54.14T). 
ARD-P is designed to measure phobic behaviors that may be interfering with an 
individual’s functioning (Morey, 1991). These results are unexpected, particularly for the 
comparison between the GAD and OD groups. There were an undetermined number of 
individuals in the OD group with a diagnosis of specific phobia. The amount of impact 
these diagnoses would have had on the mean elevation of ARD-P for the OD group is 
uncertain, however. One implication of the results found here is that the ARD-P subscale 
may not be adequately differentiating between specific phobias and generalized worry as 
related to their impact on individual functioning. Future research could address this 
concern by examining the results of the ARD-P subscale for individuals diagnosed with 
specific phobias and GAD. 
The ANX scale and ANX-A subscale were determined to be valid for the purpose 
of detecting the presence of GAD in university counseling center clients. Furthermore, it 
appears that they are useful for differentiating between GAD, MDD, and OD. The hit 
rates for the GAD, MDD, and OD groups on the ANX scale and ANX-A subscale were: 
(1) GAD, 93.7% and 83.5%, (2) MDD, 52.6% and 44.4%, and (3) OD, 58.6% and 49.0%. 
The mean elevations for the GAD, MDD, and OD groups on the ANX scale and ANX-A 
subscale were: (1) GAD, 75.80T and 71.22T, (2) MDD, 63.47T and 60.72T, and (3) OD, 
64.41T and 61.71T. 
Overall, the DCC for GAD was determined to be invalid for detecting the 





scales/subscales demonstrated acceptable hit rates. The findings for the DCC for GAD 
are consistent with the results obtained for the DCC for MDD. Based upon a comparison 
between the mean elevations in the MDD sample used by Morey (1991) and the DCC for 
MDD, it was hypothesized that the overall lack of validity demonstrated by the DCC for 
MDD with university counseling center clients was unlikely a result of significant 
differences in presentation of MDD with this population. Although a similar comparison 
could not be made for the DCC for GAD due to the lack of reported mean elevations for a 
GAD sample (Morey, 1991), it is not entirely unreasonable to assume that the overall 
lack of validity demonstrated by the DCC for GAD with university counseling center 
clients was also unlikely a result of significant differences in presentation of GAD with 
this population. 
Taken together, all of these results and hypotheses provide further support for the 
aforementioned concern regarding the validity of all the DCC’s. As such, it appears there 
is substantial need for future research to examine the validity of each of the DCC’s. 
Meanwhile, I suggest that considerable caution be exercised when attempting to use the 
DCC’s for the purpose of diagnosis. 
Proposed Diagnostic Consideration Clusters for MDD and GAD 
Due to the surprising results of the analyses on the DCC’s for MDD and GAD, I 
decided to perform post-hoc analyses using the data from the present study to develop 
DCC’s for MDD and GAD that would be more appropriate to use with university 





are typically elevated or suppressed when a particular disorder is present (Morey & 
Hopwood, 2007). As such, it could be stated that the goal of the DCC’s is to detect the 
presence of specific disorders. Based on this goal, the most precise DCC for a given 
disorder would be composed of the scales/subscales that most frequently meet criteria for 
elevation or suppression when the PAI is administered to individuals from that diagnostic 
group. Determining which scales/subscales would be most appropriate is not a simple 
task as several factors influence the likelihood that each individual in a diagnostic group 
would demonstrate similar scale/subscale elevations and suppressions relative to their 
MCE. 
The design of a valid DCC is facilitated by prior knowledge of scale/subscale 
elevations for a given diagnosis. One process that can be used to select scales/subscales 
involves examining the mean scale/subscale elevations for a given diagnosis; however, it 
is important to be aware of certain issues associated with this approach. First, when 
looking at an individual PAI profile, it is clear that the scales/subscales that are above or 
below the cutoffs for relative elevation and suppression meet criteria, but this is not 
necessarily true when mean PAI profile data is being examined. For example, if the full 
scale and subscale graphs for MDD and GAD in Appendix E are inspected, it is easy to 
visualize the scales/subscales that are above or below the cutoffs for relative elevation 
and suppression. However, these graphs use scale/subscale values that represent the 
average scale/subscale scores of all the participants from each diagnosis. As such, it is not 





suppression would also meet criteria for the majority of individuals with that diagnosis. 
The reason for this is that the amount of variability within a diagnostic group for that 
particular scale/subscale would greatly impact the percentage of individuals who meet 
criteria. 
One way to account for within-group variability on a given scale/subscale is to 
take the standard deviation into consideration. Based on the assumption that the data for 
each scale/subscale will be normally distributed for a given diagnostic group, it is 
possible to make use of the available knowledge related to this type of data. In particular, 
we can calculate the percentage of participants that will exist above and below a 
particular scale/subscale score based on the standard deviation. The selection of 
scales/subscales for the proposed DCC’s for MDD and GAD with university counseling 
center clients was made using the preceding information. 
The process for scale/subscale selection described below was used for the MDD 
and GAD diagnostic groups separately. The first step involved computing the absolute 
value of the difference between each individual mean scale/subscale T score and the 
mean MCE (e.g., for MDD group, mean DEP-C = 73.43T; mean MCE = 57.60T; so DEP-
C minus mean MCE = 15.83T). In essence, the result of this calculation for each 
scale/subscale provided information regarding its distance from the mean MCE. These 
computed values were referred to as elevation/suppression. 
The second step involved multiplying the standard deviation of each 





For instance, using a normal distribution, we know that from 0.5244 standard deviations 
below the mean, 70% of the area under the normal curve exists above that point. 
Therefore, to help determine the various mean T scores needed by each individual 
scale/subscale to achieve a 70% hit rate, the standard deviation of each scale/subscale 
was multiplied by 0.5244 (e.g., for MDD group, DEP-C SD = 14.17T; so DEP-C SD 
times 0.5244 = 7.43T). Basically, the result of this calculation for each scale/subscale 
provided information regarding how far past the boundary for elevation or suppression its 
mean T score needed to be in order to achieve the desired hit rate. These results were 
referred to as SD-scaled (e.g., for MDD group, DEP-C SD-scaled = 7.43T; mean MCE = 
57.60T; boundary for elevation = mean MCE + 5.0 = 62.60T; thus the mean DEP-C T 
score must be 7.43T above 62.60T to achieve a minimum hit rate of 70%). 
The final step involved subtracting the value of SD-scaled for each scale/subscale 
from the value of elevation/suppression for each scale/subscale (e.g., for MDD group, 
DEP-C elevation/suppression = 15.83T; DEP-C SD-scaled = 7.43T; so 15.83T minus 
7.43T = 8.40T). Essentially, the result of this calculation for each scale/subscale provided 
the location of the point above which 70% of the participants T scores resided. This point 
was in relation to the mean MCE so that a negative value indicated a point below the 
mean MCE, and a positive value indicated a point above the mean MCE. Given that the 
boundaries for elevation and suppression are defined to be 5.0T above and below the 
MCE, any scale/subscale that had a final result of positive 5.0T or greater could be 





reason why a positive 5.0 value is used for both elevation and suppression is because the 
choice was made early in the process to create the elevation/suppression values as 
absolute values so they would all be positive). 
The preceding calculations had been designed, organized, and conducted in such a 
manner that it would be easy to change the value for the amount of standard deviation 
required to meet a desired hit rate. This allowed multiple analyses to be performed using 
various hit rates. It was decided to execute analyses with hit rates ranging from 60% to 
95%, at intervals of 5%. Appendix K contains the proposed DCC’s for MDD and GAD 
with university counseling center clients, including how they vary based on the hit rate 
selected. 
Examination of the results for the proposed DCC’s for MDD and GAD provide 
some interesting insights. First, doing a comparison between the theoretical hit rates and 
observed hit rates using the scales/subscales of the original DCC’s for MDD and GAD, 
suggests that the method chosen to develop the proposed DCC’s is valid. In particular, for 
the MDD group, DEP-A showed an observed hit rate of 83.7% and a calculated 
theoretical hit rate greater than 80% and less than 85%. DEP-C had an observed hit rate 
of 80.7% and a calculated theoretical hit rate greater than 75% and less than 80%. MAN-
G demonstrated an observed hit rate of 70.4% and a calculated theoretical hit rate greater 
than 70% and less than 75%. The four remaining scales/subscales of the DCC for MDD – 
SCZ-T, DEP-P, SUI, and SCZ-S – had observed hit rates less than 60%, and none of 





The scales/subscales of the original DCC for GAD showed similar results. In 
particular, ANX showed an observed hit rate of 93.7% and a calculated theoretical hit 
rate greater than 90% and less than 95%. ANX-A had an observed hit rate of 83.5% and a 
calculated theoretical hit rate greater than 80% and less than 85%. The two remaining 
scales/subscales of the DCC for GAD, ARD and SCZ, had observed hit rates less than 
60% and neither of them were included in the analysis for the 60% or greater theoretical 
hit rate. Taken together, the above results provide evidence in support of the validity of 
the proposed DCC’s for MDD and GAD with university counseling center clients. 
The choice to use multiple hit rates in the development of the proposed DCC’s for 
MDD and GAD was based on a few considerations. First, it is conceivable that depending 
on the particular situation the DCC’s are being used for, the clinician may want to include 
any scale/subscale with a 60% or greater hit rate, or he/she may choose to use only the 
scales/subscales with much higher hit rates. Secondly, by including additional 
scales/subscales in the DCC’s that meet criteria at a lower frequency, it provides the 
clinician with the opportunity to make decisions based on the relative importance of a 
given scale/subscale. For instance, for a particular patient, if the scales/subscales with the 
highest probability of meeting the associated criteria fail, and yet most of the 
scales/subscales with the lowest probability of meeting criteria succeed, it is plausible 
that the patient is not presenting with the disorder related to the DCC under 
consideration. Conversely, if a given patient meets criteria for the scales/subscales with 





reasonable to conclude that the patient does have the disorder associated with the DCC 
being used. However, if the relative probabilities of the various scales/subscales were not 
known, it is likely that the choice would be based on number of hits versus misses. In this 
case, the opposite diagnostic decisions would be made for the scenarios described above. 
Perhaps the most surprising aspect of the results for the proposed DCC’s for 
MDD and GAD is the number of scales/subscales that meet criteria with considerable 
frequency. In particular, selecting 75% as the minimum required hit rate, the DCC for 
MDD would contain only three scales/subscales: (1) DEP-A, (2) DEP, and (3) DEP-C. 
Using the same hit rate, the DCC for GAD would contain only four scales: (1) ANX-C, 
(2) ANX, (3) ANX-A, and (4) ANX-P. 
Several concerns arise from the above findings. First, each DCC contains only the 
scale/subscales related to its associated diagnosis. Given this, it could be argued that the 
DCC’s are not useful for assisting in diagnosis because a clinician could simply examine 
the elevation for each of the related scale/subscales without needing to make the 
additional calculations required for the DCC’s. Secondly, a hit rate of 75% means that 
only three out of four patients being administered the PAI would show a particular DCC 
scale/subscale elevation. Although this may be acceptable to some clinicians, it is 
presumable that many practitioners would choose not to rely on something that may not 
detect 25% of the relevant scale/subscale elevations. Furthermore, as a result of the hit 
rate being for each individual scale/subscale rather than the DCC as a whole, when only 





scales/subscales would meet criteria for a given PAI profile. This provides additional 
support to the notion that DCC’s may not be a useful tool for diagnostic assessment. 
Discriminant Analysis on MDD and OD 
The hypothesis for the DA on MDD and OD was that the following scales and 
subscale would be found to discriminate between the two diagnostic groups: (1) DEP, (2) 
SUI, and (3) MAN-G. The results of the DA revealed that together, (1) DEP, (2) ANX, 
(3) SUI, and (4) ANT-E were capable of accurately classifying a given PAI profile into 
the appropriate diagnostic group. Two of the three hypothesized scales/subscales were 
selected for inclusion in the discriminant function, and one additional scale, ANX, was 
also chosen. At first glance these findings may appear to only partially support the 
hypothesis, but further examination can provide understanding into how the selection of 
ANT-E is consistent with the reasoning that was used in predicting the inclusion of 
MAN-G. Furthermore, beyond the scales/subscales that were hypothesized, the addition 
of the ANX scale can be elucidated when certain aspects of the data are taken into 
consideration; first, however, clarification will be provided regarding the meaning and 
appropriate interpretation of the DA results. 
It is important to have a clear understanding of two aspects regarding this and the 
other two DA’s: (1) what the results do and do not tell us about the data in general and 
the PAI scales/subscales in particular, and (2) how the results can be utilized. As already 
described (see Chapter 3, section on Analyses), DA can be used for multiple purposes 





cases into the appropriate group with a reasonably high level of accuracy. Additionally, 
when the choice is made to use the stepwise method of DA, as was the case for the 
present study, these discriminant functions will contain the fewest independent variables 
(PAI scales/subscales) necessary for the task. Furthermore, the variables that are selected 
for inclusion will be those that provide the greatest discriminatory power. From this, it 
would be easy to assume that the scales/subscales that possess the largest differences in 
elevation between groups would be the ones included in the discriminant function. Were 
this the case, one could simply look at the graphs showing the mean scale/subscale 
elevations of the two diagnoses under consideration (see Appendix E for the full scale 
and subscale graphs that contain only MDD and OD together) and find the 
scales/subscales that visibly showed the maximum discrepancies between the diagnoses; 
however, it turns out this is not the case. The reason the process is not that simple is due 
to both the nature of the data in this study as well as the characteristics of the stepwise 
procedure (again, see Chapter 3, section on Analyses, for more details). 
An examination of the results of the DA on MDD and OD that utilizes the 
aforementioned graphs can help elucidate the process leading to the eventual discriminant 
function. When the stepwise method selects the first scale/subscale, it looks for the one 
exhibiting the greatest difference between the two diagnoses; however, for reasons 
described in the previous section for the proposed DCC’s for MDD and GAD, this will 
not necessarily be the scale/subscale with the greatest between groups mean elevation 





Looking at the full scale and subscale graphs in Appendix E as well as the numerical 
values for the mean scale/subscale elevations (Appendix F) for MDD and OD, it is clear 
that the three scales/subscales with the largest between groups differences are DEP, DEP-
C, and DEP-A. As it turns out, the first scale/subscale selected by the DA is the DEP full 
scale. 
Based on the prior description regarding the attributes of the stepwise procedure, 
the next scale/subscale selected is unlikely to be either DEP-C or DEP-A because they 
are highly correlated with the DEP scale. Returning to the graphs, the SUI scale appears 
to have the next largest between groups disparity. Interestingly, it is not the next 
scale/subscale selected by the DA; the ANX scale is. A look at the graph shows that 
MDD and OD have nearly identical mean elevations on the ANX scale, which begs the 
question why it was chosen, particularly over the SUI scale. Again, the correlation issue 
is likely the reason for this. In particular, SUI is conceptually expected to be highly 
correlated with MDD, and with that in mind, it seems plausible that it is not the next most 
discriminatory scale/subscale given that the DEP scale has already been included. Once 
the ANX scale is added second, the SUI scale is determined to contain the next greatest 
discriminatory power on the variance that remains between the diagnoses once the 
variance accounted for by the first two scales, DEP and ANX, has been removed. 
The fourth and final scale/subscale chosen for the discriminant function was the 
ANT-E subscale. A quick look at the graphs would suggest that there are at least a few 





especially MAN-G and BOR-I; however, they are passed over in favor of ANT-E. The 
explanation for this is likely due to correlation issues again. Although it is not possible to 
state with certainty what actually led to this result, what is certain is that ANT-E provided 
the greatest reduction in the remaining variance between the two diagnoses. Following 
the inclusion of ANT-E, the DA determined there were no additional scales/subscales 
that could significantly improve the discriminatory power of the function. 
Working through the stepwise selection process for the DA on MDD and OD 
helps clarify what the scales/subscales chosen for inclusion in the discriminant function 
do and do not explain about the data under consideration. First, the scales/subscales that 
are selected by the DA do not provide insight into which scales/subscales have the 
greatest T score differences between the two diagnostic groups. Second, the inclusion of a 
scale/subscale in a discriminant function does not indicate anything with regards to the 
degree of elevation exhibited by that scale/subscale in either diagnostic group. 
Specifically, inclusion does not signify that the scale/subscale elevation will typically be 
very low, very high, or moderate. As such, when examining an individual PAI profile for 
the purpose of interpretation, using only the knowledge that these four scales/subscales 
comprise the discriminant function does not indicate the characteristics of the profile in 
general or each individual scale/subscale in particular. In fact, about the only statement 
that can be made with significant confidence is that when these specific scales/subscales 





individual PAI profile into the appropriate diagnostic category with a level of accuracy 
that is significant. 
As already noted, the DCC’s were designed in such a way that the PAI 
scales/subscales they contain signify those which are most important and potentially 
helpful to evaluate when interpreting an individual profile for specific diagnostic 
possibilities. Specifically, the scales/subscales of a particular DCC should be those that 
exhibit the highest and lowest elevations in the PAI profile for the corresponding 
diagnosis. Based on the discussion above, it becomes clear that the scales/subscales 
selected by DA are not able to provide the same type of information. Furthermore, the 
scales/subscales chosen for the DCC’s are based solely on profile data that represents one 
specific diagnosis, while those selected by DA are based on a comparison of the profile 
data for two separate diagnostic categories. Taken together, all of the aforementioned 
differences between the construction of a DCC and a discriminant function create a 
situation where it is not valid to make direct, one-to-one comparisons between the 
scales/subscales of the DCC’s and those selected by DA. Although there is modest 
overlap of the scales/subscales obtained in the computations for the DCC’s and the DA’s 
in this study, the basis on which a given scale/subscale is selected by each analysis is 
generally quite different, even though it may appear on the surface to be for the same or 
similar reasons. 
As noted above, two of the scales/subscales selected by the DA were contrary to 





the discriminant function while the MAN-G subscale was not. The MAN-G was 
predicted for inclusion because the mean profile for the MDD sample Morey (1991) used 
reveals that the typical elevation for MAN-G is well below 50T. For several reasons 
described in the section regarding the DCC for MDD, MAN-G is expected to be 
suppressed for an individual suffering from MDD.  It turns out that ANT-E, which is 
intended to be a measure of egocentricity (Morey, 1991), measures very similar 
constructs. In fact, Morey (1991) suggests that high scores on ANT-E are indicative of a 
person who experiences little guilt or remorse; therefore, low scores on ANT-E may 
indicate excessive guilt, which is one of the nine criterion symptoms for MDD (APA, 
2000). Therefore, for reasons very similar to those of MAN-G, it is expected that ANT-E 
would be suppressed in individuals presenting with MDD. 
The ANX scale was included in the discriminant function although it was not 
hypothesized to be one of the selected scales/subscales. An examination of the 
characteristics of the OD group can provide a possible explanation for the selection of 
ANX by the DA. As previously defined, the OD group is composed of every client who 
was not diagnosed with: (1) MDD with no co-morbid Axis I disorder, or (2) GAD with 
no co-morbid Axis I disorder. Notably, due to the selected criteria for the MDD and GAD 
groups, it is possible for the OD group to include, among others, a diagnosis that consists 
of: (1) MDD and GAD, (2) MDD and one or more (non-GAD) co-morbid Axis I 
disorder(s), and (3) GAD and one or more (non-MDD) co-morbid Axis I disorder(s). In 





exact number is not known at the time of this writing because that data was not recorded 
during the process of categorizing the PAI profiles into the diagnostic groups chosen for 
this study. 
Although exact figures are not available at the time of this writing, it is possible to 
generate an estimate of the number of participants in the OD group with an MDD or 
GAD diagnosis. As mentioned earlier, a report that contained diagnostic information was 
produced using Titanium software. The report provides information for each of the 
diagnoses described in the DSM-IV-TR (APA, 2000), including the percentage of clients 
who received that diagnosis. Unfortunately, given the significant number of possible 
variations for the MDD diagnosis (single episode, recurrent, mild, moderate, full 
remission, etc.), it is not a simple matter to estimate how many participants in the OD 
group had a diagnosis of MDD. After removing the MDD diagnoses that were given a 
specifier of either partial or full remission (the MDD group was created using the same 
guideline), the remaining MDD diagnoses were received by 29.8% of clients. This figure 
is likely misleading (to an unknown degree) due to the possibility that at one point a 
given client could have received a diagnosis of MDD, single episode, mild, and then later 
received a diagnosis of MDD, recurrent, mild. The potential also exists that a particular 
client could have received two separate diagnoses of MDD that varied only in level of 
severity (mild, moderate, or severe with/without psychotic features). Each of these 





but it is not possible from the data available at the time of this writing to determine the 
extent this value might be exaggerated. 
Given the unknown error in the approximation of clients diagnosed with MDD, it 
was decided to proceed with the current value while bearing in mind that it is likely 
somewhat inflated. Based on the value of 29.8%, approximately 459 clients in the sample 
used for this study received a diagnosis of MDD. We know that 135 clients received a 
diagnosis of MDD with no co-morbid Axis I disorder, which leaves around 324 clients in 
the OD group with a diagnosis of MDD and one or more additional Axis I disorder(s). 
The percentage of clients who received a diagnosis of GAD was 18.0% (GAD does not 
have multiple diagnoses as does MDD), which extrapolates out to an estimate of 277 
clients. The GAD group consisted of 79 participants, which leaves approximately 198 
participants in the OD group with a diagnosis of GAD and one or more additional Axis I 
disorder(s). 
Returning to the unpredicted inclusion of the ANX scale in the discriminant 
function for MDD and OD, the preceding discussion regarding the composition of the 
OD group provides one possible explanation for this finding. Specifically, the OD group 
contained roughly 198 participants who had GAD as a part of their diagnostic profile. 
This may account for the ability of ANX to discriminate between the MDD and OD 
groups. This hypothesis becomes even more plausible when the mean scale elevations for 
ANX are examined. In particular, the MDD (M = 63.47T; SD = 11.68) and OD (M = 





1T of each other. Based on the idea that significant differences in scale elevations 
between two diagnostic groups should best provide discriminant power, it seems 
unimaginable that the ANX scale could discriminate between the MDD and OD group 
when the corresponding mean elevations are so similar. However, an examination of the 
standard deviations reveals a proportionally larger variability in the OD group. It is 
conceivable that this variation occurred due to the 198 or so GAD diagnoses in the OD 
group having elevated scores on the ANX scale. If this is indeed the case, then it is very 
believable that ANX could discriminate between MDD and OD despite the similar mean 
scale elevations. 
Although the above suppositions regarding the individual scales/subscales that 
comprise the discriminant function for MDD and OD cannot be verified, there are some 
aspects of the DA results that are definitive. In particular, the standardized canonical 
coefficients assigned to each scale/subscale of the discriminant function (see Appendix 
H) provide useful information in that they can be used to assess the importance of the 
unique contribution to the discriminant function of each scale/subscale. Put another way, 
they indicate the relative importance of the scales/subscales in predicting diagnostic 
group. The standardized canonical coefficient with the maximum absolute value for the 
discriminant function for MDD and OD belongs to the DEP scale (0.992); the ANX scale 
is the second highest (-0.810). The interpretation of these findings is that the DEP scale 
has the most predictive power of the four scales/subscales selected for the discriminant 





the DEP scale. The ANT-E subscale, which has the lowest standardized canonical 
coefficient (-0.330), is roughly only one-third as powerful as the DEP scale for predicting 
diagnostic category. Importantly, these coefficients change whenever a scale/subscale is 
added or removed from the discriminant function; therefore, what cannot be inferred 
from these results is how much predictive power the DEP, ANX, SUI, or ANT-E 
scales/subscales have compared to each of the remaining PAI scales/subscales. 
Once a discriminant function has been created, it can be used to classify 
individual PAI profiles into one of two groups. This step involves multiplying the T score 
of each scale/subscale in the discriminant function by its corresponding unstandardized 
canonical discriminant coefficient, and summing those values to provide a single 
numerical result. When the computed result is above a certain cutoff point, that 
participant is classified into one diagnostic group, and when below the cutoff, it places 
the participant into the other diagnostic group. To aid in this process, it is recommended 
that prior probabilities (priors) be set proportional to group size when the two groups do 
not have equal sample sizes, which is the case in the present instance (MDD: n = 135; 
OD: n = 1327). Priors essentially act as weights in such a way as to direct more 
participants towards the group with the larger prior value, and fewer participants towards 
the group with the smaller prior value. For example, if the classification of MDD and OD 






Initially, when the classification was calculated for each of the MDD and OD 
participants, the above proportional priors were used; however, this led to a significant 
problem. With priors set to group size, 90.7% of the original grouped cases were 
correctly classified, and classification was successful in 99.0% of the OD group, but only 
8.9% of the MDD group. In terms of number of participants, this meant that only 12 of 
the 135 participants in the MDD group were classified in the MDD category. 
When priors were set equal (.5 and .5), classification was successful in 68.1% of 
the MDD group, and 74.0% of the OD group. Of the original grouped cases, 73.5% were 
correctly classified. Although the total hit rate is significantly lower in this second 
classification (73.5% versus 90.7%), and the OD group’s classification rate decreased 
from 99.0% to 74.0%, the MDD group increased from being correctly classified 8.9% of 
the time to 68.1%. Given that the goal of this DA was to create a discriminant function 
that was capable of taking the PAI profile of any client seeking treatment and detect, 
identify and diagnose the presence of MDD. To this end, it was decided that the loss in 
accuracy of correctly classifying the OD group was much less important than the gains 
for the MDD group with priors set equal. 
Furthermore, the composition of the OD group raises some interesting questions 
regarding the second and final classification using the MDD and OD derived discriminant 
function. In particular, the 26.0% of OD participants who were “incorrectly” classified 
into the MDD group represent 345 participants. Earlier, a rough estimate for the number 





Axis I disorder(s) was calculated and determined to be around 324. Perhaps the similarity 
between this estimated value and the actual number of participants from the OD group 
who were classified as being in the MDD group is purely coincidence, but it is very 
intriguing to consider the possibility that the majority of the 345 are comprised of the 
rough estimate of 324 participants with an MDD diagnosis as part of the clinical picture. 
Unfortunately, given the available data at the time of this writing there is no way to 
determine if this is in fact the case, or even what percentage of the 345 has an MDD 
diagnosis. If this proposed theory is even partially correct, it could be argued that the 
“lower” hit rate for the OD group when using equal priors is actually a more accurate 
representation of the PAI profiles being investigated than the 99.0% hit rate when priors 
were set to group size. 
The previous discussion highlights one of the limitations of the present DA. At a 
basic level, one interpretation of the results from running a DA on MDD and OD is that 
you can use the resultant discriminant function to examine an individual PAI profile and 
predict if the client has MDD with no co-morbid Axis I disorder(s) or some other some 
other diagnosis. If, however, the goal were to create a discriminant function that could  
detect the existence of MDD regardless of the presence of another Axis I disorder, the 
discriminant function developed here cannot be assumed to perform such an action. It is 
suggested that a follow-up study be conducted that places any PAI profile with an 
associated MDD diagnosis into the MDD group to determine how, if at all, the resulting 





Discriminant Analysis on GAD and OD 
It was hypothesized that (1) the ANX-A subscale and (2) the SCZ full scale would 
be found to discriminate between the GAD and OD diagnostic groups. The results of the 
DA revealed that together, (1) ANX-C, (2) BOR-I, and (3) DEP-A were capable of 
accurately categorizing a given PAI profile into the appropriate diagnostic group. Neither 
of the two hypothesized scales/subscales was selected for inclusion in the discriminant 
function, and one additional scale, DEP-A, was included. On the surface, these results do 
not support the predicted outcome; however, for several reasons described in the previous 
section, it is not a trivial matter to theorize what scales/subscales would be selected by 
DA. Furthermore, in the case of the GAD group, a mean profile was not available for use 
in assisting with scale/subscale predictions as was the case for the MDD group. If the 
process described in the previous section for the selection of scales by the DA for the 
MDD and OD groups is followed here, insight into the 3 subscales that were selected in 
this DA can be gained. It is left as an exercise for the reader to step through the 
procedure. As a reminder, Appendix E contains the full scale and subscale graphs that 
display the GAD and OD groups together. 
The inclusion of ANX-C as opposed to the predicted ANX-A is consistent with 
the result obtained from the computations used to create the proposed DCC for GAD, 
which showed the ANX-C subscale to possess the highest hit rate of any scale/subscale 
for the ANX diagnostic group (see Appendix K). In fact, the mean scale elevation for 





diagnostic groups created for this study (see Appendix F). As such, it is clear why it was 
selected as the first scale/subscale by this DA. 
As with the DA for MDD and OD, there was an unexpected scale chosen by the 
DA for GAD and OD: in this instance, the DEP-A subscale. For the DA on MDD and 
OD, the ANX scale was selected, and due to the OD group containing large numbers of 
GAD diagnoses, it is intuitive that the ANX scale would help discriminate between the 
two diagnostic groups. Following the same reasoning, it is understandable that the OD 
group’s large number of MDD diagnoses, which was estimated to be around 324, would 
account for the ability of DEP-A to discriminate between the GAD and OD diagnostic 
groups in the present DA. 
Reviewing the standardized canonical coefficients for the DA on GAD and OD 
(see Appendix I) reveals that, as would be expected, the ANX-C subscale (1.197) has the 
most predictive power of the three subscales used in the discriminant function. The BOR-
I (-0.596) and DEP-A (-0.466) subscales are each a little less than half as powerful for the 
purpose of predicting. 
Similar to the classification for the MDD and OD groups, the selection of priors 
that were proportional to group size was problematic for GAD and OD. In fact, the ratio 
for the classification is even worse than it was for MDD and OD (GAD: n = 79; OD: n = 
1327). For the same reasons explained in the classification of MDD and OD, it was 





values, classification was successful in 82.3% of the GAD group, and 77.2% of the OD 
group. Of the original grouped cases, 77.5% were correctly classified. 
A dynamic consistent with the one observed in the MDD and OD classification 
presented itself here as well. Specifically, the 22.8% of OD participants who were 
“incorrectly” classified into the GAD group represent 303 participants. As estimated 
before, roughly 198 participants in the OD group have a diagnosis of GAD and one or 
more additional Axis I disorder(s). As such, the OD group had about 50% more 
participants placed in the GAD group than the approximate number who had a diagnosis 
of GAD as part of the clinical picture (303 versus 198), which is not as accurate as the 
results obtained from the MDD and OD classification (345 versus 324). However, the 
result discovered here still generates the intriguing possibility that a significant number of 
the 303 who were “incorrectly” classified are comprised of the estimated 198 participants 
with a GAD diagnosis as part of the clinical picture. As with the previous classification, it 
is not possible to determine the degree to which this relationship may exist due to the lack 
of necessary data at the time of this writing. 
Once again, consistent with the DA on MDD and OD, the above discussion 
highlights one of the limitations of the present DA. At a basic level, one interpretation of 
the results from running a DA on GAD and OD is that you can use the resultant 
discriminant function to examine an individual PAI profile and predict if the client has 
GAD with no co-morbid Axis I disorder(s) or some other some other diagnosis. If, 





GAD regardless of the presence of another Axis I disorder, the discriminant function 
developed here cannot be assumed to perform such an action. It is suggested that a 
follow-up study be conducted that places any PAI profile with an associated GAD 
diagnosis into the GAD group to determine how, if at all, the resulting discriminant 
function would differ from the one just created. 
Discriminant Analysis on MDD and GAD 
The hypothesis for the DA on MDD and GAD was that the following scale and 
subscales would be found to discriminate between the two diagnostic groups: (1) DEP-A, 
(2) ANX-A, (3) SUI, (4) MAN-G, (5) SCZ-S, and (6) SCZ-T. The results of the DA 
revealed that together, (1) ANX, (2) DEP-A, (3) BOR-S, (4) SCZ-P, (5) SOM-S, and (6) 
MAN-G could accurately classify a given PAI profile into the appropriate diagnostic 
group. Thus, only two of the six hypothesized scales/subscales were selected for 
inclusion in the discriminant function, but one, ANX, was very similar to the suspected 
ANX-A except that rather than the anxiety subscale being selected, the full scale was 
chosen. As with the DA on GAD and OD, these results do not support the predicted 
outcome; however, for several reasons already discussed, accurately predicting 
scale/subscale selection for DA is often not possible. Additionally, the hypothesized 
scales/subscales for this DA suffered from the same issue as the DA for GAD and OD; 
namely that there was no mean GAD profile to utilize in developing the predicted 
scales/subscales. Once again, following the aforementioned process in the DA on MDD 





elucidated. It is left as an exercise for the reader to step through the procedure. As a 
reminder, Appendix E contains the full scale and subscale graphs that display the MDD 
and GAD groups together. 
Some differences between this DA and the first two that were performed are 
important to mention. First, the relationship between the two groups under consideration 
for this DA is significantly different than the others. In particular, each of these groups 
was composed of participants who met very narrowly defined criteria related to 
diagnosis. In the first two DA’s, one of the two groups was extremely heterogeneous and 
also included participants who had portions of their clinical presentation that overlapped 
with the comparison group. In the present DA, this was not the case as each group 
contained only the designated diagnosis, which theoretically should have led to much 
more consistent PAI profiles with the additional benefit of minimal overlap with the 
comparison group. Additionally, an enormous improvement in the ratio of group size 
exists between these two groups. 
An examination of the standardized canonical coefficients for the DA on MDD 
and GAD (see Appendix J) reveals that the ANX (-1.139) and DEP-A (0.707) 
scale/subscale have significantly more predictive power than the other four subscales in 
the DA. This finding provides incremental validity for the depression and anxiety 
scales/subscales of the PAI, particularly with a university counseling center population. 





scales/subscales of the PAI, depression and anxiety, would provide a significant 
proportion of the discriminatory power. 
Classification for the DA on MDD and GAD was executed differently due to the 
improvement in ratio of group size (GAD: n = 79; MDD: n = 135). As such, it was 
determined that this classification could be performed as is typically recommended, 
which entails using group sizes for the choice of priors. Using these values, classification 
was successful in 93.3% of the MDD group, and 89.9% of the GAD group. Of the 
original grouped cases, 92.1% were correctly classified. In terms of the number of PAI 
profiles misclassified, 9 of the 135 profiles from the MDD group were misclassified as 
GAD, and 8 of the 79 profiles from the GAD group were misclassified as MDD. The 
exceptionally high hit rates obtained in this DA are likely influenced by a few factors. 
First, the ability to select group sizes for the priors boosts accuracy above that seen for 
the first two DA’s. Also, the well-defined nature of each group presumably facilitated the 
ability to discriminate between them. 
The applicability of the discriminant function computed for MDD and GAD is 
significantly different from the previous two discriminant functions, and this 
distinctiveness sheds light on an important limitation. Essentially, the discriminant 
functions computed for MDD and OD, and GAD and OD, are capable of the following: 
given a PAI profile of any university counseling center client, the diagnosis will be 
determined to be either MDD (or GAD) with no co-morbid Axis I disorder, or something 





detecting the presence of the associated disorder (MDD or GAD), or to help rule-out the 
disorder. In stark contrast, the discriminant function for MDD and GAD provides the 
ability to do the following. Given a PAI profile of a university counseling center client 
who has either MDD with no co-morbid Axis I disorder, or GAD with no co-morbid Axis 
I disorder, the diagnosis will be determined, and thus differentiated, with a high degree of 
confidence. To this end, it could be said that this function is useful for the task of 
differentiating between MDD and GAD when the diagnosis has been narrowed to be one 
of the two. As such, this discriminant function has a very specific application, while the 
other two could presumably be used with every client. The benefit of such a precise 
purpose is the extremely high level of accuracy achieved. Alternatively, the broader 
application provided by the first two discriminant functions comes at the cost of a 
significant decrease in accuracy. 
Similar to the limitations noted for the first two discriminant functions, this one 
was developed using data from participants who did not have a co-morbid Axis I 
disorder. If the goal was to have a discriminant function that could be used for the task of 
differentiating between MDD and GAD regardless of the presence of other Axis I 
disorders, the discriminant function developed here cannot be assumed to perform such 
an action. It is suggested that a follow-up study be conducted that places any PAI profile 
with an associated MDD or GAD diagnosis into the corresponding diagnostic group to 









There are a number of limitations in the present study, and those applicable to 
only one or a few of the parts have been discussed in the corresponding sections above. 
One limitation that applies to the study as a whole is the use of clinician’s diagnoses as a 
criterion measure. It is widely accepted that considerable variability exists between 
individual clinician’s diagnostic impressions. Given that the accuracy of the diagnoses 
used in this study were not verified by a second clinician (except in those cases where the 
treating clinician was a graduate student being supervised by a licensed psychologist), it 
is conceivable that variation among clinicians adversely affected the diagnoses used for 
classification in this study. To the extent that this occurred, the myriad analyses 
conducted would have been based on PAI data that were erroneously believed to be 
associated with correct diagnoses. Although the consistent results achieved in many 
aspects of this study would suggest otherwise, it is still possible that variation in clinician 
diagnoses adversely affected the results obtained. 
Furthermore, it is possible that the clinician’s diagnostic decisions were 
influenced by reviewing the results of the PAI prior to making a diagnosis. Although the 
PAI results do provide interpretive hypotheses regarding diagnosis, they are merely 
suggestions, and the clinician is still expected to consider all possible diagnoses that are 





variable that could be controlled, nor is it possible to estimate the impact it may have had 
on diagnostic decisions. Again, as mentioned above, the consistency of the results 
obtained across various analyses and diagnostic groups in the present study suggests that 
the diagnoses used were accurate and reliable. 
The choice to use DA for the purpose of developing discriminant functions that 
could be utilized for diagnostic classification of individual PAI profiles may have led to 
problematic results. Other statistical methods exist that can be used for classification 
purposes, and perhaps different results would have been obtained had another method of 
analysis been chosen, such as logistic regression. One weakness of multivariate 
approaches such as DA is that weights (canonical discriminant function coefficients in 
the present study) may not generalize well across various samples. The reasons for this 
are that the weights can be affected by sample size, as well as the number and weighting 
of predictors (Bernstein, 1988). Two directions for future research include: (1) using a 
different statistical method on the data in this study to create the corresponding 
discriminant functions, and then comparing those results to the ones obtained here, and 
(2) conducting DA on data from new samples to determine how well the weights 
obtained in this study generalize to another sample. 
The data used for this study came from a single counseling center at a large 
southeastern university; as such, the generalizability of this study is limited. It is possible 
that the student population sampled here differs from other universities of varying size 





counseling center of this university present with significantly different concerns than 
those at other universities. Although the CSCMH study (Locke, 2009) demonstrated that 
the same types of clients and problems tend to be seen by all counseling centers 
regardless of their parent institution, it is still possible that there are important variations 
in the students seeking services at this counseling center. Replication of this study at 
multiple university counseling centers across the U.S. may bolster the generalizability of 
the results obtained here. 
Future Directions 
A number of future directions for research have been proposed throughout this 
study. Combining several of the results and nuances that were revealed in this study, the 
question arises as to how else the PAI might be utilized for the purpose of diagnosis. In 
particular, are there methods that could provide more accurate diagnoses than those 
developed to date? Similarly, could methods be discovered that provide equivalent 
diagnostic accuracy of existing methods, yet with less analysis, effort, or time involved to 
achieve the results? 
One such possibility comes to mind based on some of the patterns observed in the 
present study, as well as research conducted by Marlowe and Wetzler (1994). The 
authors used DA to develop a number of discriminant functions using other popular 
personality assessment instruments. They found that most of the functions created were 
able to significantly discriminate patients who were depressed, manic, or psychotic from 





found little improvement in diagnostic efficiency when compared to the use of single-
scale elevations at specified cut scores. The findings obtained by Marlowe and Wetzler 
(1994), and several patterns observed during the analyses of the present study, suggest 
the need to conduct research on the PAI that compares the use of complicated equations 
like those developed with DA, and simpler methods of analysis such as individual scale 
elevations that make use of cut scores to determine inclusion in a diagnostic category. 
Conclusions 
Overall, the results of this study indicated that the Personality Assessment 
Inventory can be used to diagnose and discriminate between Major Depressive Disorder 
and Generalized Anxiety Disorder in a University Counseling Center. However, the 
ability of the PAI to be utilized for this purpose varied as a function of the application of 
the PAI results. In particular, it was found that the Diagnostic Consideration Clusters for 
MDD and GAD were not capable of diagnosing the intended disorders, and were thus 
incapable of discriminating between MDD and GAD. Furthermore, based on additional 
analyses and the development of DCC’s for MDD and GAD using the data from the 
present study, I questioned the viability of using DCC’s for the purpose of diagnosis and 
suggested future research examine the validity of DCC’s for other psychiatric disorders to 
aid in addressing the question of viability. 
In contrast to the DCC’s, discriminant functions were created that were found to 
accurately diagnose and discriminate between, (1) MDD and all other disorders, (2) GAD 





were effective for the task of diagnosis and discrimination, they require significant effort 
to develop initially and then additional effort and time to apply to PAI data. Given this 
drawback to using discriminant functions, I questioned if it would be possible to obtain 
similar results with less time and effort. Research conducted by Marlowe and Wetzler 
(1994) suggests that it may be possible to achieve similar levels of diagnostic efficiency 
by examining single-scale elevations at specified cut scores; therefore, future research 
could expand upon the work done by these authors to include additional psychiatric 
diagnoses and assessment instruments, particularly the PAI. 
Given the prevalence of MDD and GAD as the two psychological disorders most 
generally treated at university counseling centers, the clinically significant distress or 
impairment they cause in important areas of functioning, and the difficulties clinicians 
face in accurately diagnosing and discriminating between MDD and GAD, the results of 
this study demonstrate a need to increase the use of the PAI as a part of the treatment 
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Major Depressive Disorder (MDD) 
 
A. Presence of one or more Major Depressive Episodes, defined as: 
 
A. Five (or more) of the following symptoms have been present during the same 
two-week period and represent a change from previous functioning; at least one of 
the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. 
Note: Do not include symptoms that are clearly due to a general medical 
condition, or mood-incongruent delusions or hallucinations. 
(1) depressed mood most of the day, nearly every day, as indicated by either 
subjective report (e.g., feels sad or empty) or observation made by others (e.g., 
appears tearful). Note: In children and adolescents, can be irritable mood.  
(2) markedly diminished interest or pleasure in all, or almost all, activities most of 
the day, nearly every day (as indicated by either subjective account or 
observation made by others). 
(3) significant weight loss when not dieting or weight gain (e.g., a change of more 
than 5% of body weight in a month), or decrease or increase in appetite nearly 
every day. Note: In children, consider failure to make expected weight gains. 
(4) insomnia or hypersomnia nearly every day 
(5) psychomotor agitation or retardation nearly every day (observable by others, 
not merely subjective feelings of restlessness or being slowed down) 
(6) fatigue or loss of energy nearly every day 
(7) feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly every day (not merely self-reproach or guilt about being 
sick) 
(8) diminished ability to think or concentrate, or indecisiveness, nearly every day 
(either by subjective account or as observed by others) 
(9) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation 
without a specific plan, or a suicide attempt or a specific plan for committing 
suicide 
B. The symptoms do not meet criteria for a Mixed Episode. 
C. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. 
D. The symptoms are not due to the direct physiological effects of a substance (e.g., 
a drug of abuse, a medication) or a general medical condition (e.g., 
hyperthyroidism) 
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of 
a loved one, the symptoms persist for longer than 2 months or are characterized 
by marked functional impairment, morbid preoccupation with worthlessness, 





Major Depressive Disorder (MDD) (continued) 
 
B. The Major Depressive Episode is not better accounted for by Schizoaffective 
Disorder and is not superimposed on Schizophrenia, Schizophreniform Disorder, 
Delusional Disorder, or Psychotic Disorder Not Otherwise Specified. 
C. There has never been a Manic Episode, a Mixed Episode, or a Hypomanic Episode. 
Note: This exclusion does not apply if all of the manic-like, mixed-like, or 
hypomanic-like episodes are substance or treatment induced or are due to the direct 
physiological effects of a general medical condition. 
 
Source:  Adapted from “Diagnostic and Statistical Manual of Mental Disorders (4th ed., 
text revision, pp. 356, 369-371),” by American Psychiatric Association, 2000, 






Generalized Anxiety Disorder (GAD) 
 
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than 
not for at least six months, about a number of events or activities (such as work or 
school performance). 
B. The person finds it difficult to control the worry. 
C. The anxiety and worry are associated with three (or more) of the following six 
symptoms (with at least some symptoms present for more days than not for the past 
six months). Note: Only one item is required in children. 
(1) restlessness or feeling keyed up or on edge 
(2) being easily fatigued 
(3) difficulty concentrating or mind going blank 
(4) irritability 
(5) muscle tension 
(6) sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying 
sleep) 
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder, 
e.g., the anxiety or worry is not about having a Panic Attack (as in Panic Disorder), 
being embarrassed in public (as in Social Phobia), being contaminated (as in 
Obsessive-Compulsive Disorder), being away from home or close relatives (as in 
Separation Anxiety Disorder), gaining weight (as in Anorexia Nervosa), having 
multiple physical complaints (as in Somatization Disorder), or having a serious illness 
(as in Hypochondriasis), and the anxiety and worry do not occur exclusively during 
Posttraumatic Stress Disorder. 
E. The anxiety, worry, or physical symptoms cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning. 
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism) 
and does not occur exclusively during a Mood Disorder, a Psychotic Disorder, or a 
Pervasive Developmental Disorder. 
 
Source:  Adapted from “Diagnostic and Statistical Manual of Mental Disorders (4th ed., 







PAI Clinical, Treatment, and Interpersonal Scales 
             
Scale       Description     
Clinical Scales 
Somatic Complaints (SOM) Focuses on preoccupation with health matters and somatic complaints 
related to somatization or conversion disorders. Subscales include 
Conversion (SOM-C), Somatization (SOM-S), and Health Concerns 
(SOM- H). 
Anxiety (ANX) Focuses on phenomenology and observable signs of anxiety with an 
emphasis on assessment across different response modalities. Subscales 
include Cognitive (ANX-C), Affective (ANX-A), and Physiological 
(ANX-P). 
Anxiety-Related Disorders (ARD) Focuses on symptoms and behaviors related to specific anxiety 
disorders. Subscales include Obsessive-Compulsive (ARD-O), Phobias 
(ARD-P), and Traumatic Stress (ARD-T). 
Depression (DEP) Focuses on symptoms and phenomenology of depressive disorders. 
Subscales include Cognitive (DEP-C), Affective (DEP-A), and 
Physiological (DEP-P). 
Mania (MAN) Focuses on affective, cognitive, and behavioral symptoms of mania and 
hypomania. Subscales include Activity Level (MAN-A), Grandiosity 
(MAN-G), and Irritability (MAN-I). 
Paranoia (PAR) Focuses on symptoms of paranoid disorders and on more enduring 
characteristics of paranoid personality. Subscales include Resentment 
(PAR-R), Hypervigilance (PAR-H), and Persecution (PAR-P). 
Schizophrenia (SCZ) Focuses on symptoms relevant to the broad spectrum of schizophrenic 
disorders. Subscales include Psychotic Experiences (SCZ-P), Social 
Detachment (SCZ-S), and Thought Disorder (SCZ-T). 
Borderline Features (BOR) Focuses on attributes indicative of a borderline level of personality 
functioning, including unstable and fluctuating interpersonal relations, 
impulsivity, affective lability and instability, and uncontrolled anger. 
Subscales include Affective Instability (BOR-A), Identity Problems 
(BOR-I), Negative Relationships (BOR-N), and Self-Harm (BOR-S). 
Antisocial Features (ANT) Focuses on history of illegal acts and authority problems, egocentrism, 
lack of empathy and loyalty, instability, and excitement-seeking. 
Subscales include Antisocial Behaviors (ANT-A), Egocentricity (ANT-
E), and Stimulus-Seeking (ANT-S). 
Alcohol Problems (ALC) Focuses on problematic consequences of alcohol use and features of 
alcohol dependence. 
Drug Problems (DRG) Focuses on problematic consequences of drug use (both prescription 





PAI Clinical, Treatment, and Interpersonal Scales (continued) 
             
Scale       Description     
Treatment Scales          
Aggression (AGG) Focuses on characteristics and attitudes related to anger, hostility, and 
aggression, including a history of aggression (physical and verbal) and 
attitudes conducive to aggressive behavior. Subscales include 
Aggressive Attitude (AGG-A), Verbal Aggression (AGG-V), and 
Physical Aggression (AGG-P). 
Suicidal Ideation (SUI) Focuses on suicidal ideation, ranging from hopelessness through 
general and vague thoughts of suicide to thoughts representing specific 
plans for the suicidal act. 
Stress (STR) Focuses on the impact of current or recent stressors in areas of family, 
health, employment, finances, and other major life areas. 
Nonsupport (NON) Focuses on a lack of perceived social support, considering both the 
level and quality of available support. 
Treatment Rejection (RXR) Focuses on attributes and attitudes theoretically predictive of interest 
and motivation to make personal changes of a psychological or 
emotional nature: a feeling of distress and dissatisfaction, willingness 
to participate, recognition of need to change, openness to new ideas, 
and a willingness to accept responsibility for actions. 
Interpersonal Scales 
Dominance (DOM) Focuses on the extent to which a person is controlling and independent 
in interpersonal relationships. Conceptualized as a bipolar dimension, 
with a dominant style at the high end and a submissive interpersonal 
style at the low end. 
Warmth (WRM) Focuses on the extent to which a person is supportive and empathic in 
personal relationships. Conceptualized as a bipolar dimension, with a 
warm, outgoing interpersonal style at the high end and a cold, rejecting 
interpersonal style at the low end. 
          
Note:  Adapted from “Personality Assessment Inventory: Professional manual,” by L.C. 






Diagnostic Consideration Clusters for MDD and GAD 
       _____ 
Relative  Relative 
Disorder  Elevation  Suppression_ 
 







GAD   ANX   ARD 
   ANX-A  SCZ 
       _____ 
Note:  Adapted from “PAI: Structural Summary-Revised,” 


































































































































































Mean PAI full scale elevations for MDD (n = 135). Solid yellow line = MCE = 57.60T; dashed yellow lines = relative 



























































































































Mean PAI subscale elevations for MDD (n = 135). Solid yellow line = MCE = 57.60T; dashed yellow lines = relative elevation 


















Mean PAI full scale elevations for GAD (n = 79). Solid yellow line = MCE = 55.54T; dashed yellow lines = relative elevation 



























































































































Mean PAI subscale elevations for GAD (n = 79). Solid yellow line = MCE = 55.54T; dashed yellow lines = relative elevation 

























































































































































































































































































































































































































































































Mean PAI Scale/Subscale Scores by Diagnostic Group and Entire Sample 
                  
                __MDDa__            __GADb__             ___ODc__             __Totald__ 
PAI Scale/Subscale    M SD  M SD  M SD  M SD  
 
Inconsistency (ICN)    52.04 7.13  48.96 6.44  50.71 7.57  50.74 7.49 
Infrequency (INF)    50.79 7.91  52.44 8.30  52.17 7.97  52.07 7.99 
Negative Impression (NIM)   57.49 10.31  51.75 8.66  55.04 10.31  55.08 10.28 
Positive Impression (PIM)   39.15 9.55  40.54 9.81  41.49 10.57  41.23 10.46 
Somatic Complaints (SOM)   53.33 8.21  52.84 8.26  52.30 9.85  52.42 9.64 
Anxiety (ANX)    63.47 11.68  75.80 10.78  64.41 13.91  64.91 13.82 
Anxiety-Related Disorders (ARD)  56.87 12.29  59.20 10.14  57.27 13.16  57.33 12.95 
Depression (DEP)    74.04 13.16  62.00 10.96  64.07 14.01  64.83 14.09 
Mania (MAN)     49.82 9.45  50.56 9.04  52.64 11.21  52.29 11.00 
Paranoia (PAR)    56.37 11.22  52.65 10.85  55.12 11.69  55.10 11.62 
Schizophrenia (SCZ)    61.21 12.20  55.33 10.31  57.99 12.50  58.14 12.41 
Borderline Features (BOR)   65.59 10.21  57.89 10.24  61.89 11.96  62.01 11.82 
Antisocial Features (ANT)   52.12 9.12  47.73 7.73  53.04 11.04  52.69 10.79 
Alcohol Problems (ALC)   50.19 9.87  48.30 8.35  50.63 11.05  50.48 10.84 
Drug Problems (DRG)   50.56 11.54  48.67 11.71  49.73 12.47  49.75 12.35 
Aggression (AGG)    52.40 10.53  49.91 10.11  51.71 11.71  51.68 11.54 
Suicidal Ideation (SUI)   64.20 18.28  52.16 14.47  54.87 14.08  55.55 14.76 
Stress (STR)     58.66 10.62  54.20 9.01  56.87 11.21  56.89 11.08 
Nonsupport (NON)    60.67 12.49  52.47 11.23  56.47 12.79  56.63 12.77 
Treatment Rejection (RXR)   36.27 8.81  39.28 9.10  40.30 10.46  39.89 10.32 
Dominance (DOM)    45.43 10.65  44.65 11.46  47.07 11.65  46.80 11.57 





Mean PAI Scale/Subscale Scores by Diagnostic Group and Entire Sample (continued) 
                  
                __MDDa__            __GADb__             ___ODc__             __Totald__ 
PAI Scale/Subscale    M SD  M SD  M SD  M SD  
 
Somatic Complaints 
Conversion (SOM-C)   50.00 7.34  50.67 8.66  50.64 10.15  50.59 9.86 
Somatization (SOM-S)  57.04 11.18  55.42 10.31  54.36 10.98  54.65 10.99 
Health Concerns (SOM-H)  51.41 8.85  51.04 7.99  50.89 10.02  50.94 9.82 
Anxiety 
Cognitive (ANX-C)   64.79 12.05  76.92 8.95  64.88 13.34  65.49 13.31 
Affective (ANX-A)   60.72 12.27  71.22 10.51  61.71 13.60  62.11 13.51 
Physiological (ANX-P)  60.62 12.26  71.09 14.95  62.17 14.34  62.49 14.34 
Anxiety-Related Disorders 
Obsessive-Compulsive (ARD-O) 49.14 11.63  53.81 10.56  51.74 12.43  51.62 12.30 
Phobias (ARD-P)   53.99 10.62  59.92 10.60  54.14 11.62  54.43 11.55 
Traumatic Stress (ARD-T)  61.08 15.42  56.27 13.30  59.35 14.70  59.34 14.71 
Depression 
Cognitive (DEP-C)   73.43 14.17  61.97 13.44  63.80 15.01  64.55 15.11 
Affective (DEP-A)   74.49 13.14  59.08 11.48  63.85 14.91  64.53 14.95 
Physiological (DEP-P)  63.60 12.31  59.58 10.65  58.31 11.83  58.84 11.90 
Mania 
Activity Level (MAN-A)  51.89 10.57  52.48 10.72  53.41 11.83  53.23 11.67 
Grandiosity (MAN-G)  46.36 10.78  47.63 9.40  49.63 10.87  49.25 10.83 
Irritability (MAN-I)   52.09 10.84  52.13 10.55  53.66 11.87  53.44 11.72 
Paranoia 
Hypervigilance (PAR-H)  57.66 13.66  54.00 11.91  57.08 13.30  56.98 13.28 
Persecution (PAR-P)   50.29 9.60  48.70 9.57  50.45 9.89  50.34 9.85 





Mean PAI Scale/Subscale Scores by Diagnostic Group and Entire Sample (continued) 
                  
                __MDDa__            __GADb__             ___ODc__             __Totald__ 
PAI Scale/Subscale    M SD  M SD  M SD  M SD  
 
Schizophrenia 
Psychotic Experiences (SCZ-P) 49.01 10.25  45.76 7.15  48.72 10.39  48.59 10.25 
Social Detachment (SCZ-S)  59.08 13.34  53.09 11.28  54.83 12.93  55.12 12.94 
Thought Disorder (SCZ-T)  66.12 15.18  62.32 12.81  63.80 15.12  63.92 15.03 
Borderline Features 
Affective Instability (BOR-A) 62.59 11.05  56.63 12.18  59.46 12.89  59.58 12.75 
Identity Problems (BOR-I)  67.96 10.97  59.19 9.78  63.30 11.96  63.50 11.88 
Negative Relationships (BOR-N) 62.51 11.39  58.33 11.49  60.09 12.20  60.21 12.12 
Self-Harm (BOR-S)   55.25 12.06  49.56 8.62  53.93 12.41  53.82 12.25 
Antisocial Features 
Antisocial Behaviors (ANT-A) 50.62 9.91  46.86 7.71  51.05 10.42  50.80 10.29 
Egocentricity (ANT-E)  49.52 8.96  48.44 7.52  52.18 10.39  51.76 10.20 
Stimulus-Seeking (ANT-S)  54.85 10.87  49.47 9.38  54.59 12.33  54.35 12.12 
Aggression 
Aggressive Attitude (AGG-A) 50.68 12.81  49.70 12.18  49.59 12.64  49.69 12.63 
Verbal Aggression (AGG-V)  49.45 10.51  48.19 12.44  49.45 12.08  49.38 11.96 
Physical Aggression (AGG-P) 51.33 11.42  48.59 8.32  50.36 11.14  50.35 11.04 
                  
Note:  MDD = Major Depressive Disorder; GAD = Generalized Anxiety Disorder; OD = Other Diagnosis; Total = entire 
sample. 







Percentage of Participants who matched Criteria for the Diagnostic 
Consideration Clusters for MDD and GAD by Diagnostic Group 
            
PAI Scale/     Group   ____ 
Subscale  MDDa   GADb   ODc   
 
MDD DCCd  2.2%   0%   0.8% 
DEP-Ae 83.7%   43.0%   54.0% 
DEP-Pe 48.1%   50.6%   37.8% 
DEP-Ce 80.7%   45.6%   54.6% 
SUIe  45.2%   16.5%   21.6% 
SCZ-Te 56.3%   54.4%   53.1% 
SCZ-Se 37.8%   22.8%   27.1% 
MAN-Gf 70.4%   64.6%   55.1% 
 
GAD DCCd   3.7%   3.8%   1.2% 
ANXe  52.6%   93.7%   58.6% 
ANX-Ae 44.4%   83.5%   49.0% 
ARDf  34.1%   15.2%   26.8% 
SCZf  18.5%   26.6%   21.9% 
            
Note:  DCC = Diagnostic Consideration Cluster; MDD = Major Depressive 
Disorder; GAD = Generalized Anxiety Disorder; OD = Other Diagnosis. 
an = 135. bn = 79. cn = 1327. dAll Scales/Subscales of the DCC. 






Standardized Coefficients and Correlations of the Significant PAI Scales/Subscales with 
the Discriminant Function for MDD and OD 
             
Correlation coefficients  Standardized coefficients 
Predictor  with discriminant function  for discriminant function  
 
DEP     .649      0.992 
SUI     .583      0.391 
ANT-E   -.235     -0.330 
ANX    -.062     -0.810 
             
Note:  Pooled within-groups correlations between discriminating variables and 
standardized canonical discriminant function. Variables ordered by absolute size of 






Standardized Coefficients and Correlations of the Significant PAI Scales/Subscales with 
the Discriminant Function for GAD and OD 
             
Correlation coefficients  Standardized coefficients 
Predictor  with discriminant function  for discriminant function  
 
ANX-C    .630     1.197 
BOR-I    -.238     -0.596 
DEP-A   -.222     -0.466 
             
Note:  Pooled within-groups correlations between discriminating variables and 
standardized canonical discriminant function. Variables ordered by absolute size of 






Standardized Coefficients and Correlations of the Significant PAI Scales/Subscales with 
the Discriminant Function for MDD and GAD 
             
Correlation coefficients  Standardized coefficients 
Predictor  with discriminant function  for discriminant function  
 
DEP-A   .498     0.707 
ANX    -.440     -1.139 
BOR-S   .211     0.391 
SCZ-P    .143     0.267 
SOM-S   .061     0.252 
MAN-G   -.050     -0.217 
             
Note:  Pooled within-groups correlations between discriminating variables and 
standardized canonical discriminant function. Variables ordered by absolute size of 






Proposed Diagnostic Consideration Clusters for MDD 
and GAD with University Counseling Center Clients 
       _____ 
Relative  Relative 
Disorder  Elevation  Suppression_ 
 
MDD   DEP-A c 
DEPc 
DEP-Cd 
      MAN-Ge 
BOR-If 
BORg   SCZ-Pg 
   ANT-Eg 
   SOM-Cg 
   ARD-Og 
MANg 
 
GAD   ANX-Ca 
   ANXb 
   ANX-Ac 
   ANX-Pd 
      SCZ-Pe 
      ANT-Af 
      ANTg 
      MAN-Gg 
      ANT-Eg 
      ALCg 
       _____ 
Note:  MDD = Major Depressive Disorder; 
GAD = Generalized Anxiety Disorder. 
a hit rate >= 95%. b 90% <= hit rate < 95%. 
c 80% <= hit rate < 85%. d 75% <= hit rate < 80%. 
e 70% <= hit rate < 75%. f 65% <= hit rate < 70%. 
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